Introduction {#s1}
============

The Notch signaling pathway enables intercellular communication in animals. It plays critical roles in diverse developmental and physiological processes, and is often mis-regulated in disease, including cancer ([@bib49]; [@bib73]). Notch signaling occurs when membrane-bound ligands such as Dll1 and Dll4 on one cell activate Notch receptors on neighboring cells ([Figure 1A](#fig1){ref-type="fig"}, *trans*-activation) ([@bib4]; [@bib61]; [@bib12]). However, other types of interactions are also known to occur. Intercellular interactions between Notch1 and the ligand Jag1 have been shown to block *trans*-activation during angiogenesis and in cell culture ([Figure 1A](#fig1){ref-type="fig"}, *trans-*inhibition) ([@bib8]; [@bib39]; [@bib36]). Additionally, Notch ligands and receptors co-expressed in the same cell have been shown to mutually inhibit one another, suppressing productive intercellular signaling ([Figure 1A](#fig1){ref-type="fig"}, *cis-*inhibition) ([@bib76]; [@bib24]; [@bib30]). Such '*cis*-inhibition' has been shown to be important in diverse developmental processes including neurogenesis, wing margin formation in Drosophila, and maintenance of postnatal human epidermal stem cells ([@bib53]; [@bib42]; [@bib33]; [@bib50]).

![Engineered CHO-K1 N1D1 + Rfng cells show ligand-dependent *cis*-activation.\
(**A**) Schematic of actual and potential *cis*- and *trans-*interaction modes in the Notch pathway. (**B**) Schematic of the N1D1 + Rfng cell line. CHO-K1 cells were engineered to express a chimeric receptor combining the Notch1 extracellular domain ('N1ECD', green) with the Gal4 transcription factor (orange) in place of the endogenous intracellular domain. When activated, released Gal4 activates a stably integrated fluorescent H2B-Citrine reporter gene (yellow) through UAS sites (brown) on the promoter. Cells also contain a stably integrated construct expressing Dll1 (red) with a co-translational (2A, white) H2B-mCherry readout ('mCH', red), from a 4-epiTc-inducible promoter. Cells also constitutively express Rfng (purple) and H2B-Cerulean ('H2B-Cer', blue). (**C**) (*Left*) Schematic of *cis-*activation assay conditions. A minority of N1D1 + Rfng (blue nuclei) cells were mixed with an excess of wild-type CHO-K1 cells (white nuclei). The typical distance between N1D1 + Rfng cells is ∆x. (*Right*) Filmstrip showing activation (Citrine fluorescence, green) of an isolated N1D1 + Rfng cell using time-lapse microscopy. Constitutive cerulean fluorescence (blue) in the same cell nucleus is also shown (see [Video 1](#video1){ref-type="video"} for additional examples). (**D**) Peak Notch activation rate in isolated N1D1 + Rfng cells (y-axis) versus distance to each of its closest neighboring N1D1 + Rfng cell (x-axis) at the point of maximum activity. One cell width is indicated by gray shaded area. Solid blue line indicates linear fit, whose flat slope suggests a cell-autonomous, distance-independent process. (**E**) Box plots showing the distribution of peak Notch activation rates in isolated N1D1 + Rfng cells prior to the first cell division in the *cis-*activation assay, for three different median Dll1 induction levels (indicated by numbers below bars; see [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"} for corresponding distributions).](elife-37880-fig1){#fig1}

###### *Cis-*activation of isolated engineered CHO-K1 cells.

Examples of isolated CHO-K1 N1D1 + Rfng cells activating prior to cell division in the *cis-*activation assay. (*Top row*) Blue channel shows fluorescence of the constitutively expressed nuclear H2B-Cerulean protein. (*Bottom row*) Green channel shows fluorescence of the Notch-activated H2B-Citrine reporter protein (also nuclear). The same intensity scales have been applied to each frame of the movie and for all cells. Interval between individual frames of the movie is 30 min. Non-fluorescent CHO-K1 cells surround each isolated fluorescent cell but are not visible.
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The ability of co-expressed Notch ligands and receptors to interact on the same cell provokes the question of whether such interactions might also lead to pathway activation ([Figure 1A](#fig1){ref-type="fig"}, '*cis-*activation'). *Cis-*activation has been postulated ([@bib31]; [@bib40]; [@bib18]; [@bib64]), but has not been systematically investigated. A key challenge in identifying and characterizing such a behavior is the difficulty of discriminating between *trans*- and *cis*-activation in a multicellular tissue context; that is, attributing any observed Notch signal to *trans* or *cis* ligand-receptor interactions. It has therefore remained unclear whether and where *cis-*activation occurs, how it compares to *trans-*activation, and how it might co-exist with *cis-*inhibition.

Here, we used single cell imaging to investigate activation in isolated cells. We find that *cis*-activation is a pervasive property of the Notch signaling pathway. It occurs for multiple ligands (Dll1, Dll4 and Jag1) and receptors (Notch1 and Notch2), and in diverse cell types, including fibroblastic CHO-K1 cells, epithelial NMuMG and Caco-2 cells, and in neural stem cells. *Cis*-activation resembles *trans*-activation in its dependence of signaling response on ligand levels, modulation by R-Fringe, and susceptibility to *cis*-inhibition at high ligand concentrations. Furthermore, *cis*-activation appears to impact the survival of neural stem cells. Finally, mathematical modeling shows that *cis*-activation could expand the capabilities of the Notch pathway, potentially enabling 'negative' Notch signaling and integration of information about levels of *cis-* and *trans-*ligand. Together, these results extend the range of Notch signaling modes and provoke new questions about how *cis*-activation could function in diverse processes.

Results {#s2}
=======

Notch1-Dll1 cells show ligand-dependent *cis*-activation {#s2-1}
--------------------------------------------------------

To analyze *cis*-activation, we sought to develop a synthetic platform that could allow tuning of Notch pathway components and quantitative single-cell read-out of pathway activation ([Figure 1B](#fig1){ref-type="fig"}). We used the CHO-K1 cell line, which does not naturally express Notch receptors or ligands and has been used in previous studies of the Notch pathway ([@bib76]; [@bib46]; [@bib57]). We engineered these cells to co-express the Notch ligand Dll1, a chimeric Notch1ECD-Gal4 receptor (N1ECD-Gal4), as well as the Gal4-activated H2B-Citrine fluorescent reporter gene that enables readout of Notch activation (Materials and methods). In these engineered cell lines, receptors are expressed constitutively. Dll1 expression can be induced using the small molecule 4-epi-Tetracycline (4-epiTc) in a dose-dependent manner, and monitored using a co-translational H2B-mCherry fluorescent protein ([@bib46]). Upon activation by Notch ligand, the chimeric N1ECD-Gal4 releases Gal4, which can travel to the nucleus and activate H2B-Citrine expression. Engineered cells also express a Radical Fringe (Rfng) gene, which enhances Notch1-Dll1 interactions through receptor glycosylation ([@bib55]). Finally, these 'N1D1 + Rfng' cells constitutively express nuclear-localized H2B-Cerulean fluorescent protein, which enables their identification in co-culture assays and time-lapse microscopy.

To discriminate *cis*-activation from *trans*-activation, we isolated individual N1D1 + Rfng cells by co-culturing a minority of N1D1 + Rfng cells (1%) with an excess of wild-type CHO-K1 cells (*'cis*-activation assay', [Figure 1C](#fig1){ref-type="fig"}, left). We first verified that their relative density was low enough to prevent *trans*-interactions between them, by confirming that a similar fraction of pure receiver cells, which express Notch1 but no ligands, were not activated by N1D1 + Rfng cells ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We then used time-lapse microscopy to measure Notch activity in N1D1 + Rfng cells in the *cis-*activation assay (Materials and methods). At intermediate Dll1 expression levels (with 80 ng/ml 4-epiTc), isolated N1D1 + Rfng cells showed clear activation ([Figure 1C](#fig1){ref-type="fig"}, right; [Video 1](#video1){ref-type="video"}). As expected for a cell-autonomous process, Notch activity, estimated by the peak rate of Citrine production, was uncorrelated with proximity to neighboring N1D1 + Rfng cells ([Figure 1D](#fig1){ref-type="fig"}). However, the activity depended strongly on ligand expression levels ([Figure 1E](#fig1){ref-type="fig"}). Interestingly, this dependence was non-monotonic, peaking at intermediate levels of Dll1 induction, but returning to baseline at high ligand levels ([Figure 1E](#fig1){ref-type="fig"}; Dll1 induction levels shown in [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). This suppression of Notch activity is consistent with the previously described phenomenon of *cis*-inhibition ([@bib24]; [@bib76]; [@bib24]). We confirmed that the same behavior could be observed in N1D1 + Rfng cells plated sparsely without surrounding wild-type CHO-K1 cells, suggesting that the phenomenon does not depend on the overall cell density ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). Together, these results suggest that Notch1 can be activated by intermediate concentrations of *cis-*Dll1, but that this *cis-*activation is dominated or replaced by *cis*-inhibition at high ligand concentrations.

We next asked how the strength of *cis-*activation compared to that of *trans-*activation, by analyzing the effect of intercellular contact on signaling levels. To control intercellular contact, we varied the fraction (relative density) of N1D1 + Rfng cells in the co-culture, using wild-type CHO-K1 cells to maintain a constant total cell density. In order to increase the throughput of the experiment, we used flow cytometry to measure activation levels after 24 hr of culture (Materials and methods). Total activation levels, which reflect a combination of *cis-* and *trans-*signaling, displayed a non-monotonic dependence on ligand expression for all N1D1 + Rfng fractions, similar to *cis-*activation alone ([Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}, cf. [Figure 1E](#fig1){ref-type="fig"}). The peak amplitude of total activation was \~ 3 fold higher than *cis*-activation at high N1D1 + Rfng cell densities, but *cis-* and total signaling peaked at the same ligand concentration ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}). These results are consistent with overall Notch activation reflecting contributions from both *cis-* and *trans-*interactions, both of which depend similarly on ligand concentration.

In principle, *cis-*activation could be an artifact of the chimeric Notch1ECD-Gal4 receptor. To test this possibility, we analyzed cells co-expressing Dll1 and the wild-type Notch1 receptor (N1^WT^). For readout, we used a previously characterized 12xCSL-H2B-Citrine reporter gene, which can be activated by cleaved NICD through multimerized CSL binding sites in the promoter region ([Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}, left panel) ([@bib76]). In the *cis*-activation assay, these 'N1^WT^D1+Rfng' cells showed *cis-*activation and non-monotonic dependence on ligand levels, similar to the responses described above for the N1ECD-Gal4 cells ([Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}, right panel). These results indicate that *cis*-activation occurs for wild-type as well as engineered receptors.

Next, we asked whether *cis*-activation occurs in cell types other than CHO-K1. We analyzed the polarized mammary epithelial cell line NMuMG ([@bib63]), which normally express the receptor Notch2 (N2) and ligand Jagged1 (J1) in addition to lower levels of Notch1 ([Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}, left). We first asked whether the components analyzed previously, Notch1 and Dll1, display similar *cis*-activation behavior in this cell type. We therefore deleted endogenous Notch2 and Jagged1 using CRISPR-Cas9 ('NMuMG-ΔN2ΔJ1', Materials and methods, [Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}, middle) and added inducible Dll1, constitutive Rfng, and the chimeric Notch1 receptor-based reporter system described above ([Figure 1---figure supplement 3C](#fig1s3){ref-type="fig"}). In addition to providing a cleaner background, the deletion of endogenous N2 and J1 also enhanced the response of N1ECD-Gal4 to Dll1 ([Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}, right), possibly by eliminating competition of the ectopic components with the endogenous Notch components. Since Notch signaling in polarized epithelial cells relies on the proper apical localization of Notch ligands and receptors ([@bib67]), and localization is often controlled through interactions occurring in the intracellular domain ([@bib9]; [@bib10]), we analyzed N1ECD-Gal4 receptors fused to different parts of the intracellular domain. We discovered that attachment of the ankyrin (ANK) domain ('N1ECD-Gal4-ANK') improved apical localization of the receptor and further enhanced signaling levels ([Figure 1---figure supplement 3D](#fig1s3){ref-type="fig"}, Materials and methods). Note that this modification appeared to be unnecessary in CHO-K1 fibroblasts, where the N1ECD-Gal4 showed similar surface localization as the full-length N1 (N1^wt^, [Figure 1---figure supplement 3E](#fig1s3){ref-type="fig"}). When these 'NMuMG N1D1 + Rfng' cells were analyzed using time-lapse microscopy in the *cis-*activation assay, isolated cells showed clear activation ([Figure 1---figure supplement 3F](#fig1s3){ref-type="fig"}, [Video 2](#video2){ref-type="video"}). This activation displayed a non-monotonic dependence on Dll1 expression ([Figure 1---figure supplement 3G](#fig1s3){ref-type="fig"}), similar to CHO-K1 cells, indicating that the *cis*-activation phenomenon could be general to multiple cell types.

###### *Cis*-activation of isolated engineered NMuMG cells.

Examples of isolated NMuMG N1D1 + Rfng cells activating prior to cell division in the *cis-*activation assay. (*Top row*) Blue channel shows fluorescence of the constitutively expressed nuclear H2B-Cerulean protein. (*Bottom row*) Green channel shows fluorescence of the Notch-activated H2B-Citrine reporter protein (also nuclear). The fluorescence image is overlaid on the DIC image (grey), in which surrounding non-fluorescent NMuMG cells can be seen. The same intensity scales have been applied to each frame of the movie and for all cells. Interval between individual frames of the movie is 30 min.
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To further examine *cis*-activation, we next asked whether *cis*-activation occurs with the endogenously expressed components (Notch2 and Jagged1) in NMuMG cells. To test this, wild-type NMuMG cells, pre-incubated with DAPT, were plated sparsely with or without continued DAPT treatment (see Materials and methods). 6 hr later, the expression levels of the Notch target gene Hes1 were analyzed using qRT-PCR. Cells removed from DAPT upregulated Hes1 levels compared to cells that remained in DAPT, and addition of ectopic Dll1 to the cells further increased Hes1 upregulation ([Figure 1---figure supplement 4B](#fig1s4){ref-type="fig"}). To verify that Hes1 upregulation occurred in isolated cells, we used single-molecule HCR-FISH ([@bib13]; [@bib14]) to detect Hes1 mRNA transcripts at the single-cell level. Similar to the bulk qRT-PCR results, this analysis showed that Hes1 was modestly upregulated in isolated wild-type NMuMG cells by 6 hr after DAPT removal ([Figure 1---figure supplement 4C](#fig1s4){ref-type="fig"}). Again, Hes1 induction levels could be increased by the addition of exogenous Dll1 ([Figure 1---figure supplement 4C and D](#fig1s4){ref-type="fig"}). These results are consistent with the conclusion that *cis*-activation occurs endogenously in NMuMG cells.

*Cis*-activation also occurred in the human colorectal adenocarcinoma cell line Caco-2, where Notch signaling is known to regulate proliferation and differentiation ([@bib66]); [@bib20]). To measure endogenous Notch activity, we transfected Caco-2 cells with the 12xCSL-H2B-Citrine reporter construct (used in [Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}). To analyze *cis*-activation, we plated the transfected cells sparsely, with or without the Notch inhibitor DAPT ([@bib26]) (see Materials and methods). After 24 hr, DAPT-treated cells displayed lower levels of Notch activation compared to untreated cells, consistent with *cis*-activation by endogenous Notch components ([Figure 1---figure supplement 4A](#fig1s4){ref-type="fig"}).

Taken together, these results demonstrate that *cis-*activation is a general aspect of Notch signaling, occurring in diverse cell types and with endogenous Notch receptors and ligands. In cells co-expressing Notch1, Dll1, and R-Fringe, *cis*-activation strength depends on ligand concentration. In CHO and NMuMG cells, *cis*-activation peaks at intermediate ligand concentrations, replaced by *cis*-inhibition at the highest ligand levels ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} and [Figure 1---figure supplement 3G](#fig1s3){ref-type="fig"}).

*Cis*-activation changes with ligand-receptor affinity {#s2-2}
------------------------------------------------------

Ligand-receptor interaction affinities differ across ligand-receptor pairs, and can be modulated by glycosyltransferases like Rfng ([@bib55]; [@bib80]; [@bib79]). Rfng is known to increase *trans* Notch1-Dll1 signaling. To understand how it affects *cis*-activation, we compared the N1D1 + Rfng line to its parental line ('N1D1'), lacking expression of Rfng. N1D1 cells showed ligand-dependent *cis*-activation, but at reduced levels ([Figure 2A](#fig2){ref-type="fig"}). As with N1D1 + Rfng, *cis-*activation dominated at intermediate Dll1 concentrations, while *cis*-inhibition dominated at high Dll1 concentrations. Further, extending the analysis of Notch activation to conditions with increased intercellular contact, we observed a similar dependence on cell fraction and Dll1 expression with and without Rfng; the two states differed in signal amplitude but not the shape of the ligand response ([Figure 2B](#fig2){ref-type="fig"}). Thus, Rfng increases the amplitude of both *cis* and *trans* signaling without affecting the overall dependence of signaling on Dll1 expression level.

![*Cis*-activation is affected by changes in ligand-receptor affinity.\
(**A**) (*Top*) Cell lines used for analyzing effect of Rfng on *cis*-activation. (*Bottom*) Plots showing mean Notch activation (reporter Citrine fluorescence normalized to background fluorescence in uninduced cells) in N1D1 (black) or N1D1 + Rfng (purple) cells expressing different levels of Dll1 (measured using co-translational mCherry fluorescence). Error bars indicate s.e.m (n = 3 replicate experiments). (**B**) Heatmaps of mean Notch activation (n = 3 replicates), relative to background reporter fluorescence, in N1D1 + Rfng (upper panel) or N1D1 (lower panel) cells induced with different \[4epi-Tc\] (columns) and cultured at different relative fractions (rows). Upper panel is the same data in [Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}, replotted for direct comparison. Rfng expression predominantly affects signal amplitude (compare intensity scales). (**C,D**) (*Top*) Cell lines used for analyzing effect of ligand on *cis*-activation of Notch1 (**C**) or Notch2 (**D**). (*Bottom*) Comparison of mean *cis-*activation in polyclonal populations ('Pop') of cells co-expressing Dll1 or the higher affinity ligand Dll4 with the indicated receptor, as a function of ligand expression, read out by co-translated H2B-mCherry fluorescence. Values represent mean of 3 replicates. Error bars indicate s.e.m. Note difference in y-axis scales between panels C and D.](elife-37880-fig2){#fig2}

We next analyzed how identity of the ligand affects *cis*-activation. Compared to Dll1, the ligand Dll4 has increased affinity for Notch1 ([@bib2]). We engineered CHO-K1 cells to stably express either an inducible Dll4-T2A-H2B-mCherry or Dll1-T2A-H2B-mCherry, along with a constitutive Notch1ECD-Gal4 Notch reporter system. To enable direct comparison, we performed the *cis*-activation analysis on polyclonal populations for the two cell lines. Compared to the Dll1-expressing cells, Dll4-expressing cells showed enhanced *cis-*activation and *cis-*inhibition, exhibiting greater peak reporter activity at intermediate ligand expression levels but comparable activity at the highest ligand expression levels ([Figure 2C](#fig2){ref-type="fig"}). Consistent with previous studies showing that Rfng does not increase Dll4-Notch1 affinity ([@bib79]), expressing Rfng in the N1D4 cells did not further increase *cis*-activation or *cis*-inhibition ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Taken together, these data suggest that stronger ligand-receptor interactions, either through Rfng or through a higher affinity Notch ligand like Dll4, enhance both *cis*-activation and *cis-*inhibition.

Notch2 shows stronger *cis*-activation but decreased *cis*-inhibition compared to Notch1 {#s2-3}
----------------------------------------------------------------------------------------

To investigate *cis-*activation with other Notch receptors, we engineered CHO-K1 cells to express a Notch2 reporter system (N2ECD-Gal4) along with inducible Dll1- or Dll4-T2A-H2B-mCherry, as described previously. Both N2D1 and N2D4 cell populations showed \~ 3 fold higher maximal *cis-*activation compared to their Notch1 counterparts ([Figure 2D](#fig2){ref-type="fig"}, note difference in scale compared to [Figure 2C](#fig2){ref-type="fig"}). Moreover, unlike Notch1, Notch2 showed similar levels of *cis*-activation by the Dll1 and Dll4 ligands ([Figure 2D](#fig2){ref-type="fig"}). Strikingly, the profile of activation was monotonic, with *cis*-activation persisting even at the highest ligand levels tested ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Together, these results indicate that Notch2 undergoes *cis-*activation, does so at a higher level than Notch1, and is not *cis*-inhibited as strongly as Notch1.

*Cis*-activation affects neural stem cell maintenance {#s2-4}
-----------------------------------------------------

To test whether *cis-*activation could impact Notch-mediated cellular behaviors, we analyzed mouse cortical neural stem cells (NSCs), in which Notch signaling regulates self-renewal and differentiation ([@bib11]; [@bib43]). Primary NSCs can be cultured and propagated in vitro under defined media conditions and cell density ([@bib19]). Bulk RNA sequencing revealed that these cells express high levels of Notch1, Dll1, and Lfng, and lower levels of Notch2 and Rfng, suggesting that NSCs have the potential to *cis-*activate ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}, Materials and methods).

To identify suitable gene targets for assaying Notch activation, we next analyzed the expression of the *Hes/Hey* genes, with or without the Notch inhibitor DAPT for 12 hr. Since NSC culture conditions include treatment with the EGF and FGF growth factors, and there is evidence for crosstalk between the growth factors and Notch signaling pathways in these cells ([@bib1]); [@bib56]), we compared Notch activation with or without the Notch inhibitor DAPT (10 µM), under standard (20 ng/ml EGF, 20 ng/ml FGF) and reduced (0.5 ng/ml EGF, no FGF) growth factor conditions (Materials and methods). Canonical Notch target genes *Hes1*, *Hes5*, and *Hey1* decreased in response to DAPT, and did so more strongly at reduced growth factor concentrations ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}).

To analyze *cis-*activation in NSCs, we plated cells at low density in reduced growth factor conditions (0.1 ng/ml EGF, no FGF), and cultured them with or without 10 μM DAPT ([Figure 3A](#fig3){ref-type="fig"}, Materials and methods). After 6 hr, we assayed mRNA transcript levels of Hes1, Hey1, and Hes5 in isolated cells using single-molecule HCR-FISH ([@bib13]; [@bib14]) ([Figure 3B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). DAPT treatment decreased Hes1, Hes5, and Hey1 by mean fold changes of 2.5 (95% confidence interval, 2.1--4.1), 1.9 (1.3--2.5), and 1.2 (1.1, 1.2), respectively, consistent with *cis*-activation of Notch target genes.

![*Cis*-activation occurs in neural stem cells and regulates survival.\
(**A**) E14.5 mouse cortical neural stem cells (NSCs) were plated sparsely and treated with ± 10 μM DAPT, cultured under growth conditions with low growth factors, and subsequently assayed for expression of Notch target genes and cell survival. (**B**) (*Left*) Representative example of an isolated NSC (top panel, DAPI-stained nucleus shown; note lack of neighboring cells within \~ 50 μm) not treated with DAPT, assayed for expression of Hes1 (green), Hey1 (red), and Hes5 (magenta) mRNA using multiplexed single-molecule HCR-FISH (see Materials and methods). (*Right*) Cumulative distribution plots of gene expression in DAPT-treated (black) and untreated (orange) cells (see Materials and methods for transcript quantification). *P-*values calculated using two-sided KS-test. See [Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"} for additional examples of isolated cells showing Hes/Hey expression. (**C**) (*Left*) Median of relative cell number in samples of isolated cells that were pre-treated with control siRNA (orange, see Materials and methods) or Dll1-targeting siRNA (grey) and cultured in complete growth medium for 24 hr. (*Right*) Median of relative cell number when the same siRNA-treated cells were cultured in low growth factor medium for 24 hr. Control siRNA treated cells were additionally treated with DAPT for this period. Error bars represent s.e.m, n = 2 biological replicates (**D**) Western blot analysis of endogenous Dll1 protein after siRNA mediated knockdown in NSCs. Note that Dll1 protein is reduced, but not eliminated, in NSC cells treated with Dll1-targeting siRNA compared to cells treated with control siRNA. GAPDH detection was used to assess protein loading. Dashed line indicates lanes spliced together from a single protein gel. (**E**) Median of relative cell number after 24 hr in samples of isolated cells plated on normal culture surfaces (orange) or on surfaces coated with recombinant Dll1ext-IgG protein ('Dplate', red, see Materials and methods). Cells were cultured in low growth factor conditions. Error bars represent s.e.m, n = 4 biological replicates.](elife-37880-fig3){#fig3}

We next asked whether *cis-*activation could potentially affect the Notch-dependent process of NSC maintenance. We treated cells with Dll1-targeting siRNA or control siRNA for 48 hr and then plated them at low density in low growth factor conditions (see Materials and methods). We also examined the effect of more complete Notch inhibition through DAPT treatment on the control siRNA-treated samples.

Under these conditions, DAPT treatment strongly decreased the number of cells after 24 hr, consistent with a role for *cis*-activation in promoting cell survival ([Figure 3C](#fig3){ref-type="fig"}, right panel). (Note, however, that we cannot rule out Notch-independent contributions of γ-secretase inhibition by DAPT). Dll1 siRNA treatment also decreased survival, albeit more weakly, likely due to the incomplete knockdown of Dll1 protein levels ([Figure 3C](#fig3){ref-type="fig"}, right panel and [Figure 3D](#fig3){ref-type="fig"}, see Materials and methods). Survival remained unaffected under high growth factor conditions, suggesting the effect was not due to general cellular toxicity caused by siRNA treatment ([Figure 3C](#fig3){ref-type="fig"}, left panel). The impact of Notch pathway downregulation on cell survival could be reversed by plating isolated cells (without siRNA treatment) on recombinant Dll1ext-IgG ligands ('Dplate'). This condition produced a striking increase in cell numbers at 24 hr ([Figure 3E](#fig3){ref-type="fig"}, Materials and methods). These results show that perturbation of Notch signaling in both directions produces corresponding changes in survival and suggest that Notch *cis*-activation can affect initial NSC survival in low growth factor conditions.

*Cis*-activation requires cell surface interactions between ligands and receptors {#s2-5}
---------------------------------------------------------------------------------

To gain insight into where *cis-*activation occurs in the cell, we tested whether cell surface ligand-receptor interactions were required for productive signaling ([Figure 4A](#fig4){ref-type="fig"}). Treatment of cells with soluble recombinant N1ECD-Fc (rN1ECD-Fc) receptors has been shown to prevent *trans-*signaling by blocking surface ligands ([@bib45]). We first confirmed that activation levels in densely-plated N1D1 + Rfng cells decreased when they were incubated in rN1ECD-Fc containing media for 24 hr, compared to IgG-treated controls ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). Interestingly, a similar decrease in activation levels could be observed in N1D1 + Rfng cells plated in the *cis-*activation assay ([Figure 4B](#fig4){ref-type="fig"}), suggesting that blocking ligand-receptor interactions at the surface reduces *cis-*activation. This effect was not limited to soluble receptor fragments; co-culturing a minority (5%) of N1D1 + Rfng cells with an excess of Notch1-only expressing cells similarly reduced *cis*-activation, and by a comparable amount ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). We further perturbed cell-surface ligand-receptor interactions by treating cells with Blebbistatin, an inhibitor of non-muscle myosin II, known to disrupt cellular adhesion and protrusions (Materials and methods) ([@bib48]; [@bib72]). Similar to rN1ECD-Fc, treatment with Blebbistatin decreased both *cis-* and *trans-*activation of N1D1 + Rfng cells to similar extents ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). Together, these results suggest that *cis*-activation requires surface presentation of the ligand, and are consistent with a model in which productive *cis* ligand-receptor interactions, like *trans* interactions, occur at the cell surface. However, a more complete understanding of the *cis*-activation mechanism will require additional analysis.

![Receptor-ligand cell surface interactions are necessary for *cis*-activation.\
(**A**) Schematics showing how soluble recombinant N1ECD-Fc protein (rN1ECD-Fc) can be used to test whether surface interactions between ligand (red) and receptor (green) are necessary for *cis*-activation. (*Left*) With intracellular *cis*-activation, addition of extracellular rN1ECD-Fc should not affect *cis-*activation levels. (*Right*) If surface interactions are necessary for *cis*-activation, rN1ECD-Fc treatment should reduce activation levels by competing with receptors for cell-surface ligands. (**B**) Comparison of mean Notch activation in N1D1 + Rfng cells incubated with rNotch1ECD-Fc receptors (magenta) or an IgG control (black) for 24 hr (see Materials and methods). Cells were plated for a *cis-*activation assay and analyzed by flow cytometry \< 24 hr post-plating. Error bars represent s.e.m (n = 3 replicate experiments). *P*-values calculated using the one-sided Student T-test. (**C**) Schematic of procedure for culturing N1D1 + Rfng cells in suspension. Plates were coated with a Silicone solution ('Si'), and cells were subsequently plated for a *cis*-activation assay (co-culture of 5 × 10^3^ N1D1 + Rfng + 150 × 10^3^ CHO-K1 cells). The plate was incubated at 37°C, 5% CO~2~ on a rocker to prevent cells from adhering to the plate surface. (**D**) (*Left*) Representative image of cells grown in adherent (blue) or suspension (red) conditions. (*Right*) Comparison of mean Notch activation levels, relative to background reporter fluorescence, in N1D1 + Rfng cells cultured for 24 hr in suspension (red) or in adherent conditions (blue), for different Dll1 expression levels (measured using co-translated mCherry fluorescence). Cells were in *cis*-activation co-culture conditions (5 × 10^3^ N1D1 + Rfng + 150 × 10^3^ CHO-K1 cells). Error bars represent s.e.m (n = 3 replicates).](elife-37880-fig4){#fig4}

We next asked whether *cis*-activation requires interactions with the culture dish surface. For example, *cis*-activation could involve focal adhesions formed at points of contact with the dish. Alternatively, it could involve cells depositing ligands on the culture surface, which *trans-*activate cell-surface receptors. To address this question, we analyzed N1D1 + Rfng *cis*-activation in a suspension culture.

To create suspension cultures, cell adhesion to the plate surface was prevented by pre-coating the surface with silicone ([@bib62]) and putting the plate on a rocker for the duration of the experiment ([Figure 4C](#fig4){ref-type="fig"}, Materials and methods). Under these conditions, N1D1 + Rfng cells (co-cultured with an excess of wild-type CHO-K1 cells as in the *cis-*activation assay, see [Figure 1C](#fig1){ref-type="fig"}) continued to show *cis*-activation ([Figure 4D](#fig4){ref-type="fig"}). We note that culturing cells in suspension caused slight reductions in cell-surface Notch1 and Dll1 levels ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}), which could account for the minor reduction in peak *cis-*activation observed in suspension cells compared to adherent cells. Nevertheless, these results suggest that *cis*-activation is a cell-autonomous process that does not require extensive interactions with the culture surface.

Together, our results support a model in which *cis-*activation arises in a cell-autonomous manner from interactions between ligands and receptors on the cell surface. More generally, the observed similarities between *cis-* and *trans-*activation in their dependence on ligand concentration and ligand-receptor affinities, and sensitivity to perturbations, could reflect a common underlying mechanism of activation.

*Cis*-activation enables integration of intra- and extracellular information and negative signaling {#s2-6}
---------------------------------------------------------------------------------------------------

To understand what underlying interactions could explain key features of *cis-*activation, we developed a series of simplified mathematical models of Notch-ligand *cis*-interactions at steady-state, and compared their behaviors to experimental observations.

We first considered the simplest case of Notch, denoted N, and Delta, denoted D, reversibly interacting in *cis* to form a single activation-competent complex, denoted *C^+^*, which can subsequently undergo cleavage to release NICD ([Figure 5A](#fig5){ref-type="fig"}, Model 0, Materials and methods). We simulated this model using 10,000 biochemical parameter sets, chosen using Latin Hypercube Sampling to uniformly cover parameter space ([@bib52]) ([Figure 5B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, Materials and methods). For each parameter set, we quantified the degree of non-monotonicity in the concentration of C^+^ as a function of the Delta production rate, α~D~ ([Figure 5B,D](#fig5){ref-type="fig"}). Model 0 did not produce non-monotonic responses ([Figure 5C](#fig5){ref-type="fig"}, Materials and methods), indicating that *cis-*activation at low ligand concentrations and *cis-*inhibition at high ligand concentrations cannot both result from a single underlying type of *cis*-complex.

![Mathematical model of *cis*-activation reveals potential roles in signal processing.\
(**A**) In each *cis*-activaiton model, Notch ('N', green) and Delta ('D', blue) interact to produce one or more *cis*-complexes, which can be active ('C^+^'), producing NICD (green arrow) or inhibited ('C^-^', red circle). In Models 2a-d, C^+^ is formed through the same interaction, but C^-^ formation differs for each of the included models. (**B**) Overview of simulations (see Materials and methods). (**C-E**) Results of simulations shown. (**C**) Percentage of parameters that lead to non-monotonic C^+^ behavior in each of the models (see Material and methods for assessment of this feature) (D) Example of non-monotonic dependence of C^+^ on Delta production rate ('α~D~'), generated in Model 2 c for one choice of parameter values. The fractional incline and decline features used to characterize the degree of non-monotonicity (and plotted in panel E) are shown. (**E**) Scatter plot of fractional incline vs. decline for each non-monotonic C^+^ profile produced by Models 2b-d. Filled black circles and associated schematic plots highlight C^+^ profile shapes corresponding to different incline vs. decline levels. (**F**) Schematic of model including both *cis*- and *trans*-activation. Notch receptors can interact with intracellular Delta ('*cis* D') or extracellular Delta ('*trans* D') to form *cis*- and *trans-*complexes, respectively. *Cis-*complexes can be either inhibited (red circle) or activating (green arrow), while *trans* complexes are activating. (**G**) Example of total activation (levels of activating *cis + trans* complexes) as a function of *cis* and *trans* D, for a single set of parameters producing non-monotonic *cis-*activation. (**H**) Corresponding sensitivity to change in *cis* D for the example in G. This sensitivity ('d(Total Activation)/d(log(*cis* D))') is defined as the change in total activation upon constant fold-changes in *cis* D levels, and is derived from G by computing the difference between adjacent columns of the total activation matrix. (**I**) Scatter plot showing median values of total activation vs. sensitivity to change in *cis* D in different regimes of *cis* and *trans* D (high *cis*/high *trans* - red, high *cis*/low *trans* - beige, low *cis*/high *trans* - orange, low *cis*/low *trans* - brown). Each circle represents results obtained using a single set of parameters in Model 2c (with *trans*-activation). (**J**) Schematic of model including *cis*- and *trans*-inhibition. Notch receptors can interact with intracellular Delta ('*cis* D', blue) or extracellular ligand ('*trans* ligand', purple) to form *cis*- and *trans*-complexes, respectively. *Cis-*complexes can be either inhibited (red circle) or activating (green arrow), while *trans* complexes cannot activate. (**K**) Dependence of total activation levels on *trans-*ligand, for *cis* D production rate corresponding to peak *cis*-activation. Each grey line represents behavior for a single set of parameters, while the black line represents the median response across all tested parameters.\
10.7554/eLife.37880.018Figure 5---source data 1.MATLAB code and parameter sets used for models in [Figure 5](#fig5){ref-type="fig"}.](elife-37880-fig5){#fig5}

We next considered a more complex model in which Notch and Delta can generate two distinct types of *cis*-complexes, C^+^ and C^-^, with only the former competent to activate ([Figure 5A](#fig5){ref-type="fig"}, Model 1, Materials and methods). However, this model was similarly unable to recapitulate non-monotonic C^+^ behavior ([Figure 5C](#fig5){ref-type="fig"}, Materials and methods).

We reasoned that a sequential process of *cis*-complex formation could generate active C^+^ and inactive C^-^ at lower and higher Delta production rates, respectively ([Figure 5A](#fig5){ref-type="fig"}). For instance, C^-^ could be formed from *C^ +^* through additional interactions of the active complex with itself (C^+^ + C^+^ → C^-^, Model 2b), through interactions with free N and D (N + D + C^+^ → C^-^, Model 2a), or interactions with ligand (D + C^+^ → C^-^, Model 2c). (Note that C^-^ has different constituents in each of these models). Alternatively, formation of C^-^ might require higher-order Notch-Delta interactions than required for formation of C^+^. For example, C^-^ could require interaction of 2 ligands with two receptors (2N + 2D → C^-^, Model 2d). In each of these models, the inactive C^-^ complex is formed through increased clustering of ligands and/or receptors compared to the active C^+^ complex. This scheme is broadly consistent with previous observations that Notch ligands and receptors can form clusters ([@bib7]; [@bib60]; [@bib57]).

Strikingly, these models produced non-monotonic C^+^ profiles more frequently than Models 0 and 1, across a similar set of parameter values ([Figure 5C](#fig5){ref-type="fig"}). For example, Model 2c gave rise to non-monotonic behavior for over 40% of tested parameter sets ([Figure 5C](#fig5){ref-type="fig"}). Moreover, when we analyzed the shape of the C^+^ profile ([Figure 5D](#fig5){ref-type="fig"}), Model 2c came closest to reproducing the experimentally observed non-monotonic shape, frequently showing nearly complete attenuation of activation at the highest Delta production rates ([Figure 5E](#fig5){ref-type="fig"}, cf. [Figure 1E](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}). Other models produced non-monotonic C^+^ profiles with more modest declines of 30--40% at the highest ligand production rates. While this analysis does not uniquely identify a specific molecular mechanism, it suggests that multiple distinct *cis*-complexes are likely required to explain the observed non-monotonic behavior.

Next, to understand how *cis* and *trans* interactions together determine signaling behavior, we incorporated *trans* interactions in Model 2c. Specifically, we assumed that *trans*-ligands interact with Notch to form productive *trans* complexes, denoted T, and do so with the same rates of formation, dissociation, and degradation as the active *cis-*complexes, C*^+^* ([Figure 5F](#fig5){ref-type="fig"}). For each non-monotonic parameter set in [Figure 5E](#fig5){ref-type="fig"}, we quantified the total concentration of active complexes (T + C^+^) across a range of *trans-*Delta levels and *cis-*Delta production rates (see Materials and methods).

Using this model, we first asked whether *cis*-activation could enable cells to distinguish between their own ligand levels and that of their neighbors. Multiple combinations of *cis-*Delta and *trans*-Delta levels produced the same level of signaling ([Figure 5G](#fig5){ref-type="fig"}), indicating that the cell cannot in general infer *cis* and *trans* Delta levels based solely on total Notch activity. However, the sensitivity of Notch activity to *changes* in *cis-*Delta differed strongly between otherwise similar signaling regimes, as illustrated for a single parameter set in [Figure 5H](#fig5){ref-type="fig"}. This could also be observed more generally across parameter sets ([Figure 5I](#fig5){ref-type="fig"}). This analysis suggests that by dynamically modulating its own ligand expression, a cell could, in principle, use *cis*-activation to compare *cis* and *trans* ligand levels.

With the same model, we next explored ways in which inhibitory *trans* ligands could combine with *cis-*activation to produce new modes of signaling. For example, Jagged1 forms inactive *trans* complexes with Notch receptors glycosylated by Lfng ([@bib70]; [@bib55]; [@bib46]). To represent this type of *trans* interaction, we incorporated an inactive *trans* complex, T^-^, in Model 2c, and analyzed the dependence of Notch activity on the concentration of *trans* ligand ([Figure 5J,K](#fig5){ref-type="fig"}, Materials and methods). At *cis-*ligand levels that produce peak *cis-*activation, the inhibitory *trans-*ligand decreased Notch activity in a dose-dependent fashion across multiple parameter sets ([Figure 5K](#fig5){ref-type="fig"}). This effect resulted from *trans*-ligands effectively competing with *cis*-ligands for a common pool of Notch receptors. In this way, *cis*-activation could enable a 'negative' mode of intercellular Notch signaling, complementing the standard activating mode, much as repression complements activation in gene regulation.

Discussion {#s3}
==========

*Cis*-activation is an example of autocrine signaling, which occurs in cytokine, Wnt, BMP, and other signaling pathways ([@bib28]; [@bib29]; [@bib5]; [@bib71]; [@bib81]). Typically, autocrine signaling occurs when molecules (e.g. hormones) released from a cell bind to and activate receptors on the cell from which they were synthesized ([@bib47]). However, membrane-anchored molecules can also produce autocrine signaling. For example, *cis*-activation by cell adhesion molecules (CAMs) helps induce neurite outgrowth during neuronal development ([@bib75]).

Autocrine signaling has been less explored in the Notch pathway ([@bib31]; [@bib40]). One reason may be that the well-known phenomenon of *cis*-inhibition appears to rule out *cis*-activation ([@bib76]; [@bib46]; [@bib54]). Additionally, it can be difficult to disentangle *cis*- and *trans*-activation in the context of a tissue or an in vitro system where *cis*-ligands and *trans*-ligands are simultaneously present ([@bib27]; [@bib38]; [@bib21]; [@bib76]).

To address these issues, we used an in vitro system that allows tunable control of ligand expression and readout of Notch activity in individual cells, across different cell densities ([@bib76]). This system enabled analysis of signaling by ligand- and receptor- expressing cells isolated from one another, either with or without other surrounding cells. It revealed that both Notch1 and Notch2 could be *cis*-activated by the ligands Dll1 and Dll4. We also detected *cis*-activation across multiple cell types using both engineered and endogenous Notch components. Thus, *cis-*activation co-exists with *trans*-activation, and resembles it in many respects ([Figure 2](#fig2){ref-type="fig"}).

*Cis-activation* could potentially play functional roles in any Notch-dependent process. In neural stem cells (NSC), c*is-*activation appears to affect cell survival ([Figure 3](#fig3){ref-type="fig"}), thus suggesting that self-renewing cells can also be self-reliant, providing their own Notch signaling. This finding could help to explain how isolated stem cells can regenerate a complex tissue, as occurs in Lgr5+ intestinal crypt organoids ([@bib68]) and mammary gland regeneration ([@bib78]), both of which are Notch-dependent.

Mathematical modeling suggests that *cis*-activation could broaden the capabilities of the Notch pathway: First, it could enable a 'negative' mode of *trans* Notch signaling, when high *cis*-activation is effectively inhibited by non-productive *trans* interactions ([Figure 5K](#fig5){ref-type="fig"}). This type of negative regulation is complementary to a previously described *trans*-inhibition mechanism where Notch1 activation by Dll4 was shown to be inhibited by the *trans*-ligand Jagged1 during angiogenesis ([@bib8]). Second, using a combination of *cis-*activation, *cis-*inhibition, and *trans-*activation could in principle enable a cell to discriminate the levels of its own (*cis*) ligands from those of its neighbors (*trans*) ([Figure 5I](#fig5){ref-type="fig"}). This property could be relevant for Notch-dependent fine-grained pattern formation through lateral inhibition circuits, in which cells coordinate their own Notch component levels with those of their neighbors ([@bib15]; [@bib6]; [@bib77]; [@bib32]).

In other systems, the combination of *cis* and *trans* signaling can produce interesting behaviors. For example, the EGFR ligand Heparin-binding EGF-like growth factor (HB-EGF) can exist in a membrane-anchored form that produces juxtacrine signaling or as a cleaved soluble form that can be involved in autocrine signaling. In MDCK cells, these isoforms produced distinct phenotypes, with cell survival and proliferation associated with the membrane-anchored isoform ([@bib65]); [@bib74]). Similarly, in yeast, rewiring of the mating pathway to create an autocrine signaling system revealed that qualitatively different behaviors ranging from quorum sensing to bimodality could be generated by tuning the relative strengths of *cis* and *trans* signaling ([@bib82]). Looking ahead, it will be interesting to see how Notch *cis-*activation and *trans-*inhibition mechanisms combine in natural developmental contexts.

Mechanistically, it remains puzzling how *cis* interactions could lead to both activation and inhibition in a ligand concentration-dependent fashion. Productive *cis*-signaling and *trans-*signaling both appear to require ligand and receptor at the cell surface, suggesting *cis*-activation may involve a mechanism distinct from *cis*-interactions previously reported to occur within cellular endosomes ([@bib18]; [@bib35]). Along with our observations that *cis-* and *trans*-signaling also share a similar dependence on ligand-receptor affinity and ligand concentrations ([Figure 1---figure supplement 2C,D](#fig1s2){ref-type="fig"}), these results suggest that *cis*-activating complexes may resemble their *trans*-activating counterparts. Structural studies have shown that ligand-receptor binding could occur in both parallel and anti-parallel orientations ([@bib17]; [@bib51]). It will therefore be interesting to see whether ligand-receptor complexes in different orientations can activate in a similar manner.

A striking feature of *cis*-activation is its non-monotonic dependence on ligand expression level, with *cis*-activation initially increasing as ligand levels increase, but ultimately giving way to *cis*-inhibition ([Figure 1](#fig1){ref-type="fig"}). Mathematical modeling enabled us to explore different ways in which *cis*-activation and *cis*-inhibition could coexist. The simplest model, which includes only a single type of *cis* ligand-receptor complex, could not reproduce this shift from *cis*-activation to *cis*-inhibition ([Figure 5A](#fig5){ref-type="fig"}, Model 1). By contrast, models that included distinct activating and inhibiting complexes generated these observed behaviors for a broad range of parameter values ([Figure 5A](#fig5){ref-type="fig"}, Model 2b-d). These results suggest that *cis*-activation and *cis*-inhibition involve the formation of distinct types of complexes.

C*is*-activation suggests new ways in which cells can integrate different types of Notch interactions. A more complete analysis of the *cis-* and *trans-* interactions among all ligand-receptor pairs, for different levels of Fringe expression, could provide a more comprehensive and predictive understanding of how cells with distinct component combinations signal to their neighbors, and to themselves, through Notch.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\          Designation                           Source or\              Identifiers                                                                                                            Additional\
  (species) or\                                                reference                                                                                                                                      information
  resource                                                                                                                                                                                                    
  ---------------------- ------------------------------------- ----------------------- ---------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene\                  Dll1                                  NCBI ID:\                                                                                                                                      
  (Mus musculus)                                               13388                                                                                                                                          

  Gene\                  Dll1                                  NCBI ID:\                                                                                                                                      
  (Homo sapiens)                                               28514                                                                                                                                          

  Gene\                  Dll4                                  NCBI ID:\                                                                                                                                      
  (Homo sapiens)                                               54567                                                                                                                                          

  Gene\                  R-fringe                              NCBI ID:\                                                                                                                                      
  (Mus musculus)                                               19719                                                                                                                                          

  Gene\                  Notch1                                NCBI ID: 4851                                                                                                                                  
  (Homo sapiens)                                                                                                                                                                                              

  Gene\                  Notch2                                NCBI ID: 4853                                                                                                                                  
  (Homo sapiens)                                                                                                                                                                                              

  Cell line\             CHO-K1                                Thermo Fisher\          Cat\# R71807\                                                                                                          [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"};\
  (Cricetulus griseus)                                         Scientific\             RRID:[CVCL_D586](https://scicrunch.org/resolver/CVCL_D586)                                                             [Figure 1---figure supplements 1](#fig1s1){ref-type="fig"}, [2](#fig1s2){ref-type="fig"} and [3](#fig1s3){ref-type="fig"};\
                                                               (T-REx CHO-K1)                                                                                                                                 [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"} and [2](#fig2s2){ref-type="fig"};\
                                                                                                                                                                                                              [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}

  Cell line\             N1D1                                  Derived from\           CHO-K1 expressing\                                                                                                     [Figure 2](#fig2){ref-type="fig"}
  (Cricetulus\                                                 CHO-K1                  pEF-hNECD-Gal4esn\                                                                                                     
  griseus)                                                                             + pcDNA5-\                                                                                                             
                                                                                       TO-Dll1-T2A-H2B-mCherry\                                                                                               
                                                                                        + pEV-UAS-H2B-Citrine                                                                                                 

  Cell line\             N1D1 + Rfng                           Derived from N1D1       CHO-K1 expressing\                                                                                                     \
  (Cricetulus\                                                                         pEF-hNECD-Gal4esn + pcDNA5-\                                                                                           [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"};[Figure 1---figure supplements 1](#fig1s1){ref-type="fig"} and [2](#fig1s2){ref-type="fig"}; [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}
  griseus)                                                                             TO-Dll1-T2A-H2B-mCherry +\                                                                                             
                                                                                       pEV-UAS-H2B-Citrine + pLenti-\                                                                                         
                                                                                       CMV-R-fringe-T2A-Puromycin                                                                                             

  Cell line\             N1WTD1 + Rfng                         Derived from CHO-K1     CHO-K1 expressing\                                                                                                     [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}
  (Cricetulus\                                                                         pcDNA3‐hN1‐mod1 +\                                                                                                     
  griseus)                                                                             pcDNA5-TO-Dll1-mCherry\                                                                                                
                                                                                       + pEV-12xCSL-H2B-Citrine +\                                                                                            
                                                                                       piggyBac CMV-R-fringe+pCS-\                                                                                            
                                                                                       H2B-Cerulean                                                                                                           

  Cell line\             NMuMG                                 ATCC                    Cat\# CRL-1636 (Wild-type\                                                                                             [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}
  (Mus\                                                                                cells used to transfect\                                                                                               
  musculus)                                                                            in piggyBac-12xCSL-\                                                                                                   
                                                                                       H2B-Citrine)\                                                                                                          
                                                                                       RRID:[CVCL_0075](https://scicrunch.org/resolver/CVCL_0075)                                                             

  Cell line\             NMuMG + Dll1                          Derived from NMuMG      Base wild-type cell line\                                                                                              [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}
  (Mus\                                                                                expressing\                                                                                                            
  musculus)                                                                            piggyBac-12xCSL-H2B-Citrine\                                                                                           
                                                                                       + piggyBac-TO-Dll1-T2A\                                                                                                
                                                                                       -H2B-mCherry-P2A-Hygromycin                                                                                            

  Cell line\             NMuMG N1D1 + Rfng                     Derived from NMuMG      NMuMG ΔN2ΔJ1\                                                                                                          [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}
  (Mus\                                                                                expressing piggyBac-\                                                                                                  
  musculus)                                                                            CMV-hNECD-Gal4-ANK\                                                                                                    
                                                                                       -T2A-H2B-Cerulean +\                                                                                                   
                                                                                       piggyBac CMV-TO\                                                                                                       
                                                                                       Dll1-T2A-H2B-mCherry-\                                                                                                 
                                                                                       P2A-Hygromycin + pEV\                                                                                                  
                                                                                       -2xHS4-UAS-H2B-Citrine-\                                                                                               
                                                                                       T2A-tTS-2xHS4-Blast-T2A-\                                                                                              
                                                                                       rTetR-HDAC4-P2A-R-fringe                                                                                               

  Cell line\             Caco-2                                ATCC (Caco-2 C2BBe1)    Cat\# CRL-2102 (Wild-type\                                                                                             [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}
  (Homo\                                                                               cells used to transfect in\                                                                                            
  sapiens)                                                                             pEV-12xCSL-H2B-Citrine)\                                                                                               
                                                                                       RRID:[CVCL_1096](https://scicrunch.org/resolver/CVCL_1096)                                                             

  Cell line\             N1D1 Pop                              Derived from CHO-K1     CHO-K1 with pEV-UAS-\                                                                                                  [Figure 2](#fig2){ref-type="fig"}
  (Cricetulus\                                                                         H2B-Citrine + pCS-H2B-\                                                                                                
  griseus)                                                                             Cerulean +\                                                                                                            
                                                                                       piggyBac-TO-Dll1-T2A-H2\                                                                                               
                                                                                       B-mCherry + piggyBac-\                                                                                                 
                                                                                       CMV-hN1ECD-Gal4 - Cell\                                                                                                
                                                                                       population (Pop)                                                                                                       

  Cell line\             N1D4 Pop                              Derived from CHO-K1     CHO-K1 with pEV-UAS-\                                                                                                  [Figure 2](#fig2){ref-type="fig"};\
  (Cricetulus\                                                                         H2B-Citrine + pCS-H2B-\                                                                                                [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}
  griseus)                                                                             Cerulean + piggyBac-\                                                                                                  
                                                                                       TO-Dll4-T2A-H2B-mCherry +\                                                                                             
                                                                                       piggyBac-CMV-hN1ECD-Gal4 -\                                                                                            
                                                                                       Cell population (Pop)                                                                                                  

  Cell line\             N2D1 Pop                              Derived from CHO-K1     CHO-K1 with pEV-UAS-H2B-\                                                                                              [Figure 2](#fig2){ref-type="fig"};\
  (Cricetulus\                                                                         Citrine + pCS-H2B-Cerulean +\                                                                                          [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}
  griseus)                                                                             piggyBac-TO-Dll1-T2A-H2B\                                                                                              
                                                                                       -mCherry + piggyBac-\                                                                                                  
                                                                                       CMV-hN2ECD-Gal4 - Cell\                                                                                                
                                                                                       population (Pop)                                                                                                       

  Cell line\             N2D4 Pop                              Derived from CHO-K1     CHO-K1 with pEV-UAS-\                                                                                                  [Figure 2](#fig2){ref-type="fig"};\
  (Cricetulus\                                                                         H2B-Citrine + pCS-H2B-\                                                                                                [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}
  griseus)                                                                             Cerulean + piggyBac\                                                                                                   
                                                                                       -TO-Dll4-T2A-H2B-mCherry +\                                                                                            
                                                                                       piggyBac-CMV-hN2ECD-Gal4 -\                                                                                            
                                                                                       Cell population (Pop)                                                                                                  

  Cell line\             NSC                                   EMD Millipore           Cat\# SCR029 (E14.5 mouse\                                                                                             [Figure 3](#fig3){ref-type="fig"};\
  (Mus musculus)                                                                       neural cortical stem cells - NSC)                                                                                      [Figure 3---figure supplements 1](#fig3s1){ref-type="fig"} and 2

  Transfected\           pEV‐UAS‐H2B‐\                         [@bib76]                N/A                                                                                                                    Reporter for\
  construct\             Citrine                                                                                                                                                                              Notch1ECD-Gal4 receptor in\
  (recombinant\                                                                                                                                                                                               CHO cells
  DNA)                                                                                                                                                                                                        

  Transfected\           pEV-2xHS4-UAS-\                       This paper              N/A                                                                                                                    Reporter for Notch1ECD-\
  construct\             H2B-Citrine-T2A-\                                                                                                                                                                    Gal4-ANK receptor in\
  (recombinant\          tTS-2xHS4-Blast-\                                                                                                                                                                    NMuMG cells (tTS was\
  DNA)                   T2A-rTetR-HDAC4-\                                                                                                                                                                    not relevant for this\
                         P2A-R-fringe                                                                                                                                                                         work and was inactivated\
                                                                                                                                                                                                              by 4-epiTc); rTetR-HDAC4\
                                                                                                                                                                                                              was used to decrease\
                                                                                                                                                                                                              Delta expression in the\
                                                                                                                                                                                                              presence of Dox;\
                                                                                                                                                                                                              Constitutive R-fringe\
                                                                                                                                                                                                              expression in NMuMG cells

  Transfected\           pEV-12xCSL‐\                          [@bib76]                N/A                                                                                                                    Reporter for Notch1\
  construct\             H2B‐Citrine                                                                                                                                                                          wild-type receptor\
  (recombinant\                                                                                                                                                                                               in CHO and Caco-2 cells
  DNA)                                                                                                                                                                                                        

  Transfected\           pEF-hN1ECD\                           This paper              N/A                                                                                                                    Notch1ECD-Gal4\
  construct\             -Gal4                                                                                                                                                                                synthetic receptor\
  (recombinant\                                                                                                                                                                                               used in CHO clones
  DNA)                                                                                                                                                                                                        

  Transfected\           pX330\                                [@bib16]                N/A                                                                                                                    Plasmid used to insert\
  construct\             (CRISPR-Cas9\                                                                                                                                                                        RNA guide sequence\
  (recombinant\          plasmid system)                                                                                                                                                                      for CRISPR knockdown
  DNA)                                                                                                                                                                                                        

  Transfected\           piggyBac-12x\                         This paper              N/A                                                                                                                    NotchWT reporter\
  construct\             CSL-H2B-Citrine                                                                                                                                                                      placed into NMuMG\
  (recombinant\                                                                                                                                                                                               WT cells but not used\
  DNA)                                                                                                                                                                                                        in this study

  Transfected\           piggyBac-CMV\                         This paper              N/A                                                                                                                    Notch1ECD-Gal4\
  construct\             -hN1ECD-Gal4                                                                                                                                                                         synthetic receptor\
  (recombinant\                                                                                                                                                                                               used in CHO populations
  DNA)                                                                                                                                                                                                        

  Transfected\           piggyBac-CMV\                         This paper              N/A                                                                                                                    Notch2ECD-Gal4\
  construct\             -hN2ECD-Gal4                                                                                                                                                                         synthetic receptor used\
  (recombinant\                                                                                                                                                                                               in CHO populations
  DNA)                                                                                                                                                                                                        

  Transfected\           pcDNA3‐hN1‐mod1                       [@bib76]                N/A                                                                                                                    Wild-type Notch1\
  construct\                                                                                                                                                                                                  receptor used in\
  (recombinant\                                                                                                                                                                                               CHO clones
  DNA)                                                                                                                                                                                                        

  Transfected\           piggyBac-CMV-\                        This paper              N/A                                                                                                                    Notch1ECD-Gal4-ANK\
  construct\             hNECD-Gal4-ANK\                                                                                                                                                                      synthetic receptor\
  (recombinant\          -T2A-H2B-Cerulean                                                                                                                                                                    used in NMuMG clones
  DNA)                                                                                                                                                                                                        

  Transfected\           pcDNA5-TO-Dll1\                       [@bib57]                N/A                                                                                                                    Inducible Delta-like1\
  construct\             -T2A-H2B-mCherry                                                                                                                                                                     ligand used in CHO\
  (recombinant\                                                                                                                                                                                               clones and populations
  DNA)                                                                                                                                                                                                        

  Transfected\           pcDNA5-TO‐\                           [@bib76]                N/A                                                                                                                    Inducible\
  construct\             Dll1‐ mCherry                                                                                                                                                                        Delta-like1-mCherry\
  (recombinant\                                                                                                                                                                                               fusion used in CHO\
  DNA)                                                                                                                                                                                                        clones with Notch1WT\
                                                                                                                                                                                                              receptor

  Transfected\           piggyBac-CMV-TO\                      [@bib57]                N/A                                                                                                                    Inducible Delta-like1\
  construct\             Dll1-T2A-H2B-\                                                                                                                                                                       ligand used in CHO\
  (recombinant\          mCherry-P2A-\                                                                                                                                                                        populations and\
  DNA)                   Hygromycin                                                                                                                                                                           NMuMG clones

  Transfected\           piggyBac-CMV-TO-\                     [@bib57]                N/A                                                                                                                    Inducible Delta-like4\
  construct\             Dll4-T2A-H2B-mCherry-P2A-Hygromycin                                                                                                                                                  ligand used in CHO\
  (recombinant\                                                                                                                                                                                               populations
  DNA)                                                                                                                                                                                                        

  Transfected\           pLenti-CMV-R-\                        This paper              N/A                                                                                                                    Constitutive R-fringe\
  construct\             fringe-T2A-\                                                                                                                                                                         expression in CHO\
  (recombinant\          Puromycin                                                                                                                                                                            N1D1 + Rfng cells
  DNA)                                                                                                                                                                                                        

  Transfected\           pCS‐H2B‐Cerulean                      [@bib76]                N/A                                                                                                                    Segmentation color\
  construct\                                                                                                                                                                                                  used in CHO cells
  (recombinant\                                                                                                                                                                                               
  DNA)                                                                                                                                                                                                        

  Transfected\           Allstar Negative\                     Qiagen                  SI03650318                                                                                                             Control siRNA,\
  construct (siRNA)      Control                                                                                                                                                                              [Figure 3C](#fig3){ref-type="fig"}

  Transfected\           Dll1 siRNA                            Thermo Fisher\          Cat\# 4390771\                                                                                                         Dll1 siRNA,\
  construct (siRNA)                                            Scientific              (ID: s65000)                                                                                                           [Figure 3C](#fig3){ref-type="fig"}

  Antibody               rabbit anti-\                         Cell Signaling\         Cat\# 5732\                                                                                                            WB (1:1000)
                         mouse Notch2                          Technologies            RRID:[AB_10693319](https://scicrunch.org/resolver/AB_10693319)                                                         

  Antibody               rabbit anti-\                         Cell Signaling\         Cat\# 2620\                                                                                                            WB (1:1000)
                         mouse Jagged1                         Technologies            RRID:[AB_659968](https://scicrunch.org/resolver/AB_659968)                                                             

  Antibody               rabbit anti-\                         Cell\                   Cat\# 2118\                                                                                                            WB (1:3000)
                         mouse GAPDH                           Signaling\              RRID:[AB_561053](https://scicrunch.org/resolver/AB_561053)                                                             
                                                               Technologies                                                                                                                                   

  Antibody               rabbit anti-\                         Kindly provided by\     Antibody 88 c                                                                                                          WB (1:2000)
                         mouse Dll1-ICD                        Gerry Weinmaster,\                                                                                                                             
                                                               UCLA                                                                                                                                           

  Antibody               ECL Rabbit IgG\                       GE Healthcare\          Cat \#NA934\                                                                                                           WB (1:2000)
                         HRP-linked whole\                     Life Sciences           RRID:[AB_772206](https://scicrunch.org/resolver/AB_772206)                                                             
                         antibody from\                                                                                                                                                                       
                         Donkey Secondary                                                                                                                                                                     

  Antibody               Anti-mouse AlexFluor\                 Thermo Fisher\          Cat\# A21202\                                                                                                          ICC (1:1000)
                         488 Secondary                         Scientific              RRID:[AB_141607](https://scicrunch.org/resolver/AB_141607)                                                             

  Other                  SuperSignal West\                     Thermo Fisher\          Cat\# 34580                                                                                                            as recommended\
                         Pico Chemiluminescent\                Scientific                                                                                                                                     per the manufacturer
                         Substrate                                                                                                                                                                            

  Other                  SuperSignal West\                     Thermo Fisher\          Cat\# 34095                                                                                                            as recommended\
                         Femto\                                Scientific                                                                                                                                     per the manufacturer
                         Chemiluminescent\                                                                                                                                                                    
                         Substrate                                                                                                                                                                            

  Recombinant\           Lipofectamine LTX\                    Thermo Fisher\          Cat\# 15338--100                                                                                                       as recommended\
  DNA reagent            plasmid transfection\                 Scientific                                                                                                                                     per the manufacturer
                         reagent                                                                                                                                                                              

  Recombinant\           ViraPower Lentiviral\                 Thermo Fisher\          Cat\# K497500                                                                                                          as recommended\
  DNA reagent            Expression System                     Scientific                                                                                                                                     per the manufacturer

  Peptide,\              Recombinant mouse\                    R and D Systems         Cat\# 4460 MG-100                                                                                                      10 ug/ml
  recombinant\           IgG2A Fc Protein                                                                                                                                                                     
  protein                                                                                                                                                                                                     

  Peptide,\              Recombinant mouse\                    R and D Systems         Cat\# 5026 DL-050                                                                                                      10 ug/ml
  recombinant\           Dll1 Fc chimera                                                                                                                                                                      
  protein                                                                                                                                                                                                     

  Peptide,\              Recombinant\                          R and D Systems         Cat\# 5267-TK-050                                                                                                      10 ug/ml
  recombinant\           mouse\                                                                                                                                                                               
  protein                Notch-1 Fc\                                                                                                                                                                          
                         chimera                                                                                                                                                                              

  Peptide,\              Recombinant human\                    [@bib76]                Kindly provided\                                                                                                       2.5 ug/ml
  recombinant\           Dll1ext-Fc fusion\                                            by Irwin Bernstein,\                                                                                                   
  protein                proteins                                                      MD at Fred Hutchinson\                                                                                                 
                                                                                       Cancer Research Center                                                                                                 

  Chemical\              DAPT                                  Sigma Aldrich           Cat\# D5942                                                                                                            1 uM (CHO cells);\
  compound, drug                                                                                                                                                                                              10 uM (all other cells)

  Chemical\              4-epi tetracycline\                   Sigma Aldrich           Cat\# 37918                                                                                                            0--200 ng/ml
  compound, drug         Hydrochloride                                                                                                                                                                        

  Chemical\              Doxycycline                           Takara Bio USA Inc      Cat\# 631311                                                                                                           1 ug/ml or 10 ug/ml
  compound, drug                                                                                                                                                                                              

  Chemical\              Dexamethasone                         Sigma Aldrich           Cat\# D4902                                                                                                            100 ng/ml
  compound, drug                                                                                                                                                                                              

  Commercial\            Miniprep kit                          Qiagen                  Cat\# 27106                                                                                                            
  assay or kit                                                                                                                                                                                                

  Commercial\            QIAquick PCR\                         Qiagen                  Cat\# 28104                                                                                                            
  assay or kit           Purification kit                                                                                                                                                                     

  Commercial\            RNeasy mini kit\                      Qiagen                  Cat\# 74106                                                                                                            
  assay or kit           for RNA extraction                                                                                                                                                                   

  Commercial\            iScript cDNA\                         Bio-Rad                 Cat\# 1708890                                                                                                          
  assay or kit           synthesis kit                                                                                                                                                                        

  Commercial\            iQ SYBR Green\                        Bio-Rad                 Cat\# 1708880                                                                                                          
  assay or kit           Supermix                                                                                                                                                                             

  Commercial\            SsoAdvanced\                          Bio-Rad                 Cat\# 172--5282                                                                                                        
  assay or kit           Universal Probes\                                                                                                                                                                    
                         Supermix                                                                                                                                                                             

  Commercial\            DNA HCR kit                           Molecular Instruments                                                                                                                          
  assay or kit                                                                                                                                                                                                

  Software,\             Cell segmentation\                    [@bib57]                N/A                                                                                                                    [Figure 1](#fig1){ref-type="fig"},\
  algorithm              and tracking                                                                                                                                                                         [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}

  Software,\             FISH Transcript\                      This paper              [https://github.com/nnandago/elife2018-dot_detection; ](https://github.com/nnandago/elife2018-dot_detection)[@bib58]   MATLAB code for\
  algorithm              detection and\                                                                                                                                                                       visualizing, segmenting,\
                         quantification                                                                                                                                                                       and detecting transcript\
                                                                                                                                                                                                              dots in FISH-labeled cells.\
                                                                                                                                                                                                              Used to generate\
                                                                                                                                                                                                              [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"},\
                                                                                                                                                                                                              [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}

  Software,\             cis-activation model                  This paper              <https://github.com/nnandago/elife2018-cis_activation_modeling>; [@bib59]                                              MATLAB code for\
  algorithm                                                                                                                                                                                                   modeling steady\
                                                                                                                                                                                                              state concentrations\
                                                                                                                                                                                                              of ligand, receptors and\
                                                                                                                                                                                                              complexes for a\
                                                                                                                                                                                                              range of parameters.\
                                                                                                                                                                                                              Used to generate [Figure 5](#fig5){ref-type="fig"},\
                                                                                                                                                                                                              \
                                                                                                                                                                                                              [Figure 5---figure supplement 5--](#fig5s1){ref-type="fig"}
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Plasmids {#s4-1}
--------

The majority of constructs used in this study have been previously described ([@bib76]). Briefly, the reporter for wild-type Notch activation was constructed from the 12xCSL plasmid (kind gift from [@bib37]), while the UAS reporter for Notch1ECD-Gal4 receptor activation was a kind gift from S Fraser ([@bib24]). The construct containing the full-length human wild-type Notch1 sequence was a kind gift from J Aster ([@bib22]). The Notch1ECD-Gal4 plasmid was generated by replacing the Notch1ICD with amino acids 1--147 and 768--881 of the yeast Gal4 protein. This construct was further modified by incorporating the sequence of the ankyrin (ANK) domain from Notch1ICD (amino acids 1872--2144) 3' to the Gal4 sequence for use in the construction of the NMuMG cell lines. Design of the Notch2ECD-Gal4 plasmid was done in a manner similar to that of the Notch1ECD-Gal4 plasmid, but with incorporation of the expression cassette into a PiggyBac vector (System Biosciences, Palo Alto, CA) for efficient transfer to the cellular genome (Note: Notch1ECD-Gal4 was also incorporated into a PiggyBac vector when used in side-by-side comparisons with Notch2). The Notch ligand containing plasmids were based on the Tet-inducible system (Thermo Fisher Scientific, Waltham, MA). For the wild-type Notch1 cell line, we constructed a plasmid containing an inducible rat Dll1 coding sequence fused to the mCherry protein sequence. All other ligand plasmids were constructed containing an inducible human Dll1 or Dll4 coding sequence fused to a viral 2A sequence that allows for co-translation of a downstream H2B-mCherry protein sequence. In the NMuMG cells and in the CHO cell populations, the ligand plasmids were constructed within a PiggyBac vector. The Radical Fringe (Rfng) constructs used were based on those described by [@bib46]. For use in CHO-K1 cells, Rfng was cloned into a pLenti expression construct from the ViraPower Lentiviral Expression System (Thermo Fisher Scientific), modified with a CMV promoter and a puromycin resistance gene. For use with the NMuMG cells, Rfng was cloned into an insulated UAS reporter construct (UAS surrounded by 2 copies of the 2xHS4 insulating element) by adding a separate cassette containing the sequence for the blastomycin resistance gene followed by a viral 2A sequence connected to the sequence for the rTetR gene fused to a HDAC4-2A-Rfng sequence. rTetR-HDAC4 (rTetS) was used to suppress constitutive Notch ligand expression in the NMuMG cells with the addition of Doxycycline to the cell media. The pCS-H2B-Cerulean plasmid was described in ([@bib76]). All cloning was done using standard molecular biology cloning techniques.

Cell culture and transfections {#s4-2}
------------------------------

### CHO-K1 {#s4-2-1}

T-REx CHO-K1 cells from Thermo Fisher Scientific were cultured as described previously ([@bib76]; [@bib46]). Cells were tested by Thermo Fisher for the presence of Mycoplasma using the Gen−Probe Mycoplasma Tissue Culture NI (MTC−NI) Rapid Detection System and found to be negative. Transfection of CHO-K1 cells was performed in 24-well plates with 800--1000 ng of DNA using the Lipofectamine LTX plasmid transfection reagent (ThermoFisher Scientific). 24 hr post-transfection, cells were split into new 6-well plates and cultured for 1--2 weeks in media containing 400 ug/ml Zeocin, 600 ug/ml Geneticin, 300 ug/ml Hygromycin, 10 ug/ml Blasticidin, or 3 ug/ml Puromycin as appropriate, and surviving transfected cells were either used as polyclonal populations or subcloned by limiting dilution.

### NMuMG {#s4-2-2}

NMuMG cells (ATCC, Manassas, VA) were cultured using the manufacturer's recommended culturing protocol with the addition of 1 mM Sodium Pyruvate and 100 U ml-1 penicillin, 100 μg ml-1 streptomycin (Thermo Fisher Scientific) to the media. These cells were authenticated by ATCC and found to be mycoplasma free by Hoechst DNA stain and agar culture. Transfection, selection and clonal isolation of NMuMG cells were performed similarly to CHO-K1 cells.

### Caco-2 {#s4-2-3}

Caco-2 C2BBe1 cells from ATCC were cultured in Dulbecco's modified Eagle's medium (DMEM, Thermo Fisher Scientific) supplemented with 10% Tet-System Approved Fetal Bovine Serum ([Takara Bio USA Inc,](http://www.clontech.com/) Mountain View, CA), 2 mM L-Glutamine, 100 U ml-1 penicillin, 100 μg ml-1 streptomycin, 1 mM sodium pyruvate, and 1X MEM Non-Essential Amino Acids Solution (Thermo Fisher Scientific). ATCC uses morphology, karyotyping, and PCR based approaches to confirm the identity of human cell lines and to rule out both intra- and interspecies contamination. These include an assay to detect species specific variants of the cytochrome C oxidase I gene (COI analysis) to rule out inter-species contamination and short tandem repeat (STR) profiling to distinguish between individual human cell lines and rule out intra-species contamination. Transfections were performed by following the Thermo Fisher Lipofectamine LTX protocol which was optimized for Caco-2 cells. 24 hr after transfection, Caco-2 cell populations were plated for experiments.

### Neural Stem Cells {#s4-2-4}

Neural stem cells derived from the E14.5 mouse cortex were purchased from EMD Millipore (Burlington, MA, Catalog No. SCR029) and cultured according to the manufacturer's protocols. Briefly, tissue-culture surfaces were coated overnight with poly-L-ornithine (10 ug/ml, Sigma-Aldrich Catalog No. P3655) and Laminin (Sigma-Aldrich Catalog No. L2020). For standard culture, cells were then plated in Neurobasal medium (EMD Millipore, Catalog No. SCM033) in the presence of 20 ng/ml recombinant FGF (EMD Millipore Catalog No. GF003), 20 ng/ml EGF (Millipore Catalog No. GF001), and Heparin (Sigma-Aldrich Catalog No. H3149). Cells were passaged using ESGRO Complete Accutase (Millipore Catalog No. SF006), cryo-preserved in medium + 10% DMSO, and typically used for experiments within six passages.

Lentiviral production and infection {#s4-3}
-----------------------------------

Lentivirus was produced using the ViraPower Lentiviral Expression System (Thermo Fisher Scientific). Briefly, 293FT producer cells were transfected with our pLenti expression construct along with the packaging plasmid mix. 48 hr post-transfection, virus containing cell media was collected, centrifuged to remove cell debris and filtered through a 0.45 um filter (EMD Millipore). Viral supernatant was added 1:2 to sparsely plated CHO-K1 cells in a total volume of 400 ul media in a 24-well plate and incubated at 37°C, 5% CO~2~. 24 hr post-infection, virus containing media was removed, and cells were plated under limiting dilution conditions in 96-well plates for clonal selection. Expression of the integrated gene was checked by qRT-PCR analysis.

RNASeq {#s4-4}
------

RNA was isolated from cells using the RNeasy Kit (Qiagen, Hilden, Germany) and cDNA libraries were prepared according to standard Illumina protocols at the Millard and Muriel Jacobs Genetics and Genomics Laboratory at Caltech. SR50 sequencing (10 libraries/lane) with a sequencing depth of 20--30 million reads was performed on a HiSeq2500. Reads were assembled, aligned and mapped to the mouse genome (mm10 assembly) using Tophat2 ([@bib44]) or RNAstar ([@bib25]) on the Galaxy platform (<https://usegalaxy.org>). Cufflinks was subsequently used on mapped reads to calculate FPKM values. RNAseq data for gene expression in neural stem cells cultured in reduced or standard growth factor conditions, and treated with or without DAPT, is available on GEO (accession: GSE113937).

CRISPR-Cas9 knockout of endogenous NMuMG Notch2 and Jagged1 {#s4-5}
-----------------------------------------------------------

Endogenous Notch2 and Jagged1 genes were knocked out in NMuMG cells using the CRISPR-Cas9 plasmid system developed by the Zhang Lab at MIT ([@bib16]). Cloning was done according to the published protocol using the pX330 plasmid and inserting a guide sequence using the following oligos for targeting mouse Notch2 or Jagged1:

### Notch2 {#s4-5-1}

mN2 C2 OligoF: 5'-CACCGGGTGGTACTTGTGTGCCGCA-3'

mN2 C2 OligoR: 5'-AAACTGCGGCACACAAGTACCACCC-3'

### Jagged1 {#s4-5-2}

mJ1 C1 OligoF: 5'-CACCGCGGGTGCACTTGCGGTCGCC-3'

mJ1 C1 OligoR: 5'-AAACGGCGACCGCAAGTGCACCCGC-3'

The guide sequence modified pX330 plasmids were transfected into NMuMG cells using the standard Lipofectamine LTX protocol (Thermo Fisher Scientific). 48 hr post-transfection, genomic DNA was harvested from the cell population, and guide sequence function was analyzed using the SURVEYOR Mutation Detection Kit (Integrated DNA Technologies Inc, Skokie, IL). After genomic knockout mutation was verified, transfected cells were placed under clonal selection using limiting dilution. Genomic DNA was isolated from clones and used to PCR amplify targeted sequences using the following primers (Integrated DNA Technologies Inc):

### Notch2 {#s4-5-3}

mN2 C2F: 5'-GTCACCCGTCTGGTATTTTGTTAC-3'

mN2 C2R: 5'-GAGCTGCTGTGATCGAAGTG-3'

### Jagged1 {#s4-5-4}

mJ1 C1F: 5'-CCAAAGCCTCTCAACTTAGTGC-3'

mJ1 C1R: 5'-CTTAGTTTTCCCGCACTTGTGTTT-3'

PCR products were purified using the QIAquick PCR Purification Kit (Qiagen) and sent for sequencing (Laragen Inc, Culver City, CA) to determine clones that contained gene knockout mutations. Gene knockout was also verified in NMuMG clones by western blot analysis of endogenous Notch2 and Jagged1 protein. Briefly, protein was harvested by lysing cells with Cell Lysis Buffer (Cell Signaling Technologies, Danvers, MA) supplemented with NuPAGE LDS Sample Buffer (Thermo Fisher Scientific), 80 mM DTT (Sigma-Aldrich, St. Louis, MO), 1.2 mM PMSF (Cell Signaling Technologies), and Halt Proteinase Inhibitor (Thermo Fisher Scientific). Protein lysate was heated at 95^°^C, followed by incubation on ice for 2 min. Lysate was centrifuged at 13 K rpm for 10 min. at 4^°^C, and 1/5^th^ was loaded onto a 4--12% Bis-Tris gel (Thermo Fisher Scientific). After soaking the gel in 20% ethanol for 10 min., protein was transferred from the gel to a nitrocellulose membrane using the iBlot Dry Blotting System (Thermo Fisher Scientific). The blot was blocked in 1xTBST, 5% dry milk, 2% BSA for 1 hr at room temp followed by overnight incubation at 4^°^C with either a rabbit anti-mouse Notch2 antibody at 1:1000 (Cell Signaling Technologies, \#5732) or a rabbit anti-mouse Jagged1 antibody at 1:1000 (Cell Signaling Technologies, \#2620) together with a rabbit anti-mouse GAPDH loading control antibody at 1:3000 (Cell Signaling Technologies, \#2118). The next day, the blot was washed and incubated with an anti-rabbit HRP conjugated antibody at 1:2000 (GE Healthcare Life Sciences, Marlborough, MA) for 1 hr at room temp followed by washing and band detection using SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific).

Availability assay for Notch1ECD-Gal4 or Notch1ECD-Gal4-ANK in NMuMG cells {#s4-6}
--------------------------------------------------------------------------

Surface staining of either Notch1ECD-Gal4 or Notch1ECD-Gal4-ANK was performed using the availability assay as described previously ([@bib46]). Briefly, cells were washed in phosphate buffered saline (PBS) and blocked in a PBS solution containing 2% BSA and 100 ug/ml CaCl~2~ while rocking for 40 min at room temperature. After blocking, cells were rocked in a PBS solution containing 2% FBS, 100 ug/ml CaCl~2~, and 10 ug/ml of recombinant mouse Dll1-Fc (rmDll1-Fc) for 1 hr at room temperature. The recombinant Dll1 protein can bind to the available (free) Notch receptors at the cell surface. After the 1 hr incubation, cells were washed 3x with PBS and incubated with a secondary antibody conjugated to an Alexa Fluor 488 dye. Cells were rocked at room temperature in the dark for 1 hr, washed 3x with PBS, and Notch localization on the cell surface was imaged on an EVOS FL Auto Cell Imaging system (Thermo Fisher Scientific).

qRT-PCR {#s4-7}
-------

Expression of Radical Fringe (Rfng) in clones was determined by quantitative RT-PCR. RNA was isolated from clonal cells using the RNeasy Mini Kit (Qiagen) following the manufacturer's protocol. 200--500 ng RNA was used to make cDNA using the iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA). 2 ul of cDNA was used in the qPCR reaction along with SsoAdvanced Universal Probes Supermix (Bio-Rad Laboratories), and primers/probes (Integrated DNA Technologies Inc) as follows:

Rfng

Probe: 5\'−6-FAM/ZEN/3\' IBFQ-CTCGTGAGATCCAGGTACGCAGC-3'

Primer 1: 5\'-TCATTGCAGTCAAGACCACTC-3'

Primer 2: 5\'-CGGTGAAAATGAACGTCTGC-3'

b-Actin (Housekeeping Gene for CHO-K1 cells)

Probe: 5\'-HEX/ZEN/3\' IBFQ-ACCACACCTTCTACAACGAGCTGC-3'

Primer1: 5\'-ACTGGGACGATATGGAGAAG-3'

Primer2: 5\'-GGTCATCTTTTCACGGTTGG-3'

GAPDH (Housekeeping Gene for NMuMG cells)

Probe: 5\'-HEX/ZEN/3\' IBFQ-AGGAGCGAGACCCCACTAACATCA-3'

Primer1: 5\'-CTCCACGACATACTCAGCAC-3'

Primer2: 5\'-CCACTCACGGCAAATTCAAC-3'

Samples were run in triplicate on a CFX96 Touch Real-Time PCR Detection System (Bio-Rad Laboratories), and relative gene expression levels were calculated using the standard delta-delta Cq method.

Expression of Hes1 in wild-type and Dll1 transfected NMuMG cells was determined by quantitative RT-PCR as described above with the use of IQ SYBR Green Supermix (Bio-Rad Laboratories). The 'mouse Hes1 primer set 2' primers (Integrated DNA Technologies Inc) from [@bib57] were used in the qPCR reaction.

Plate-bound Dll1 {#s4-8}
----------------

Coating of tissue culture plates with recombinant human Dll1^ext^-Fc fusion proteins (kind gift from I Bernstein) was done as previously reported ([@bib57]). Briefly, Dll1^ext^-Fc proteins were diluted to 2.5 ug/ml in 1xPBS (Thermo Fisher Scientific), and the solution was used to coat the tissue-culture surface for 1 hr at room temperature with rocking. Post-incubation, the solution was removed and cells were plated for the experiment.

Single molecule HCR-FISH detection of Notch targets in NMuMG and NSCs {#s4-9}
---------------------------------------------------------------------

### Experimental protocols {#s4-9-1}

NMuMG cells - Cells were pre-treated with 10 uM DAPT for at least 2 days before plating at 3 × 10^3^ cells/24-well tissue culture treated ultrathin glass film bottom plates (Eppendorf, Hamburg, Germany) with or without DAPT. All cells were treated with 100 ng/ml Dexamethasone (Sigma-Aldrich) at the time of plating. 6 hr post-DAPT removal, cells were fixed using 4% formaldehyde.

Neural Stem cells - NSCs were cultured in standard high growth factor containing media (see cell culture and transfections section above), and plated on 10 ug/ml poly-L-ornithine and 50 ug/ml Laminin-coated glass plates, at a surface density of \~4 cells/mm^2^. At the time of plating, cells were transferred to low growth factor conditions (0.1 ng/ml EGF, 5 ug/ml Heparin, no FGF), with or without 10 μM DAPT. 6 hr post plating, cells were fixed using 4% formaldehyde.

Prescribed protocols were followed for hybridizing DNA probes to target genes (*Hes1*, *Hey1*, and *Hes5*) and amplifying bound probes ([@bib14]). Briefly, fixed cells were incubated overnight at 37°C with 10 pairs of probes per gene diluted in 30% formamide-containing buffer. Subsequently, probes were removed and cells were washed at 37°C. Then, DNA amplifiers, designed to detect bound probes and coupled to one of three Alexa Fluor dyes (488, 546, or 647), were added to the sample, and amplification allowed to proceed at room temperature for \~50 min. Samples were then washed in high salt solution (5x SSC with Tween), and stained with DAPI, prior to imaging.

### Imaging {#s4-9-2}

Samples were imaged at 60x (1.3 NA, oil) on an inverted epi-fluorescence microscope (Nikon Ti: Nikon Instruments Inc, Melville, NY) equipped with an LED light source (Lumencor, Beaverton, OR) and hardware autofocus. Fields of view that contained between 1--3 well-separated cells were picked manually and Z-stacks were acquired over 16 μm at each position.

### Analysis {#s4-9-3}

Custom MATLAB (2015a, Mathworks) software was used to semi-automatically segment cells based on autofluorescence in the 488 channel. mRNA transcripts typically appeared as 3--5 voxel-wide high-intensity dots in the images. Previously used MATLAB software for detecting dots ([@bib34]) was adapted to automatically detect dots in images based on user-defined thresholds. For direct comparison, the same thresholds were applied to data from DAPT-treated and untreated samples. Segmentation and dot detection code have been deposited on GitHub (<https://github.com/nnandago/elife2018-dot_detection>; copy archived at <https://github.com/elifesciences-publications/elife2018-dot_detection>).

*Cis*-activation and relative density assays {#s4-10}
--------------------------------------------

CHO-K1 engineered cell lines were pre-incubated with 1 uM of the gamma-secretase inhibitor DAPT (Sigma-Aldrich) and various concentrations of the tetracycline analog, 4-epiTetracycline (4-epiTc, Sigma-Aldrich) 48 hr prior to the setup of assays. For the *cis*-activation assay, cells were washed to remove DAPT, counted, and plated sparsely at 5 K cells per 24-well plate, surrounded by 150K wild-type CHO-K1 cells. 4-epiTc was added back into the media (0, 20, 35, 50, 80, or 200 ng/ml) and the cells were either incubated at 37°C, 5% CO~2~ for \<24 hr before analysis by flow cytometry or imaged using time-lapse microscopy. For the 'control' *cis*-activation assay, 4K 4-epiTc pre-induced N1D1 + Rfng cells were plated along with 4K N1 receiver cells (no ligand present), and 750K CHO-K1 cells per 6-well plate. Cells were analyzed for activation by flow cytometry (see 'Flow cytometry analysis' section below). Relative density assays were performed using the same setup conditions as the *cis*-activation assay, but with varying ratios of engineered:wild-type cells plated. Keeping total cell numbers at 150 K cells per 24-well plate, either 5K, 10K, 25K, 50K, 75K or 100K engineered cells were plated along with wild-type CHO-K1 cells. For the *cis*-activation and relative density assays using Blebbistatin treated cells, assay setup was done exactly as mentioned above but with the addition of 10 uM (±)-Blebbistatin (Sigma-Aldrich) added to the cell media at the time of plating.

For NMuMG cells, *cis*-activation and density assays were performed just like those with CHO-K1 cells. However, cells were pre-incubated in 10 uM DAPT with or without the addition of 1 ug/ml or 10 ug/ml Doxycycline ([Takara Bio USA Inc](http://www.clontech.com/)) for 3 days in order to decrease ligand expression levels prior to assay setup. Cells were treated with 100 ng/ml Dexamethasone (Sigma-Aldrich) at time of plating for each assay.

Caco-2 cells were pre-incubated with 10 uM DAPT for 1 day prior to transfection. 24 hr post-12xCSL reporter transfection, the cells were washed, counted and plated sparsely at 3.5 K cells in a 24-well plate for the *cis*-activation assay, with or without the addition of DAPT. \< 24 hr after plating, cells were analyzed by flow cytometry.

*Cis*-activation assay in suspension {#s4-11}
------------------------------------

For performing the *cis*-activation assay with cells in suspension, 24-well 10 mm diameter glass No. 1.5 coverslip plates (MatTek Corp., Ashland, MA) were coated with the siliconizing reagent Sigmacote (Sigma-Aldrich) to prevent cells from adhering to the plate surface. Cells were plated as mentioned previously and placed on a rocker at 37°C, 5% CO~2~ overnight before analysis by flow cytometry.

Notch receptor/ligand blocking assay {#s4-12}
------------------------------------

Engineered CHO-K1 cells were pre-incubated in 1 uM DAPT, with and without the addition of 4-epiTc, for 2 days prior to the start of the assay. Cells were then incubated with either 10 ug/ml mouse IgG~2A~ control protein or 10 ug/ml mouse Notch1 Fc chimera protein (R and D Systems, Minneapolis, MN) along with DAPT and 4-epiTc overnight at 37°C, 5% CO~2~. The next day, cells were washed, counted, and plated at 5 K cells per 24-well plate along with 150K wild-type CHO-K1 cells for a *cis*-activation assay, or at 150 K cells per 24-well plate for a relative density assay with the addition of 4-epiTc. Cells grown similarly, but in the absence of 4-epiTc, were used as a control. \< 24 hr post-plating, cells were analyzed by flow cytometry.

NSC survival assay {#s4-13}
------------------

### Experimental Protocols {#s4-13-1}

NSCs, cultured in standard high growth factor containing media (see cell culture and transfections section above), were plated on 10 ug/ml poly-L-ornithine and 5 ug/ml Laminin-coated plastic surfaces (12-well TC-treated plates, Corning Inc) at a surface density of \~20 cells/mm^2^. At the time of plating, cells were transferred to low growth factor conditions (0.1 ng/ml EGF, 5 ug/ml Heparin, no FGF), with or without 10 μM DAPT. 12 hr post plating, cells were fixed using 4% formaldehyde. Samples were then stained with DAPI prior to imaging.

### Imaging {#s4-13-2}

Samples were imaged at 20x (0.75 NA, air) in an inverted epi-fluorescence microscope (Olympus IX81) equipped with an LED lightsource (XCite LED) and hardware ZDC2 autofocus. 484 600 μm x 600 μm fields of view were acquired from across the well for each sample.

### Analysis {#s4-13-3}

Custom MATLAB (2015a, Mathworks) software was used to automatically segment nuclei based on DAPI staining. The number of nuclei were counted for each of the different samples.

Dll1 knockdown in NSCs {#s4-14}
----------------------

### Experimental Protocols {#s4-14-1}

1 × 10^6^ NSCs, cultured in standard high growth factor containing media (see cell culture and transfections section above), were nucleofected with 100 pmol of Silencer Select siRNA targeting mouse Dll1 (5'-CGAUGACCUCGCAACAGAAtt-3', Life Technologies) or Allstar negative control siRNA (Qiagen). Cells were nucleofected using mouse neural stem cell-specific reagents (Lonza Bioscience) in an Amaxa 2b nucleofector (Program A-033, Lonza Bioscience). They were subsequently cultured for 48 hr and then plated sparsely, in duplicate, for a cell survival assay as described above.

### Imaging {#s4-14-2}

Samples were imaged at 20x (0.75 NA, air) in an inverted epi-fluorescence microscope (Nikon Ti) equipped with an LED lightsource (Lumencor Sola). 49 fields of view were acquired from across the well for each sample.

### Analysis {#s4-14-3}

Custom MATLAB (2015a, Mathworks) software was used to automatically segment nuclei based on DAPI staining. The number of nuclei were then counted for each of the different samples.

Western blot analysis of Dll1 knockdown in NSCs {#s4-15}
-----------------------------------------------

NSCs treated with control or Dll1-targeting siRNA and plated for a cell survival assay, as mentioned in the previous section, were collected for western blot analysis of Dll1 knockdown. More specifically, an equal number of siRNA treated cells were harvested for protein and processed as previously described (see CRISPR-Cas9 knockout of endogenous NMuMG Notch2 and Jagged1 section). The blot was blocked in 1xTBST, 5% dry milk, 2% BSA for 1 hr at room temp followed by overnight incubation at 4^°^C with a rabbit anti-Dll1-ICD antibody at 1:2000 (88c, a generous gift from Gerry Weinmaster at UCLA) together with a rabbit anti-mouse GAPDH loading control antibody at 1:3000 (Cell Signaling Technologies, \#2118). The next day, the blot was washed and incubated with an anti-rabbit HRP conjugated antibody at 1:2000 (GE Healthcare Life Sciences) for 1 hr at room temp followed by washing and band detection using SuperSignal West Femto Chemiluminescent Substrate (Thermo Fisher Scientific).

Time-lapse setup, image acquisition and analysis {#s4-16}
------------------------------------------------

### Experimental setup {#s4-16-1}

For imaging, CHO-K1 cells were plated in 24-well 10 mm diameter glass No. 1.5 coverslip plates (MatTek Corp.) coated with 5 ug/ml hamster Fibronectin (Oxford Biomedical Research, Rochester Hills, MI) in complete cell media. NMuMG cells were plated in 24-well tissue culture treated ultrathin glass film bottom plates (Eppendorf) in complete cell media.

### Acquisition {#s4-16-2}

Movies were acquired at 20X (0.75 NA) on an Olympus IX81 inverted epifluorescence microscope (Olympus, Tokyo, Japan) equipped with hardware autofocus (ZDC2), an iKon-M CCD camera (Andor, Concord, MA) and an environmental chamber maintaining cells at 37°C, 5% CO~2~ with humidity throughout the length of the movie. Automated acquisition software (Metamorph, Molecular Devices, San Jose, CA) was used to acquire images every 30 min in multiple channels (YFP, RFP, CFP) or differential interference contrast (DIC), from multiple stage positions.

### Analysis {#s4-16-3}

Custom MATLAB code (2013a, MathWorks) was used to segment cell nuclei in images based on constitutive Cerulean fluorescence. Briefly, the segmentation procedure uses built-in edge detection MATLAB functions and adaptive thresholds to detect nuclear segments. Nuclear segments were then matched in pairs of images corresponding to consecutive time frames, and thus tracked through the duration of the movie. Single-cell tracks were subsequently curated manually to correct for errors in segmentation/tracking. Fluorescence data was extracted from nuclear segments by calculating the integrated fluorescence within the segment and subtracting a background fluorescence level estimated from the local neighborhood of the segment. This fluorescence was linearly interpolated across time frames where nuclei could not be segmented automatically. Division events were detected automatically, and fluorescence traces were corrected for cell division by adding back fluorescence lost to sister cells. The resulting 'continuized' traces were smoothed and the difference in fluorescence between consecutive time frames was calculated. A smoothed version of this difference was used as an estimate of production rate of the fluorescent protein.

Flow cytometry analysis {#s4-17}
-----------------------

For analysis of cells by flow cytometry, cells were trypsinized in 0.25% Trypsin-EDTA (Thermo Fisher Scientific) and resuspended in 1x Hanks Balanced Salt Solution (Thermo Fisher Scientific) supplemented with 2.5 mg/ml Bovine Serum Albumin (Sigma-Aldrich). Resuspended cells were filtered using 40 um cell strainers (Corning Inc, Corning, NY) into U-bottom 96-well tissue culture treated plates. Cells were analyzed on a MACSQuant VYB Flow Cytometer (Miltenyi Biotech, Bergisch Gladbach, Germany) located at the Caltech Flow Cytometry Facility (Caltech, Pasadena, CA). Data was analyzed in MATLAB using custom software (EasyFlow) ([@bib3]), and forward and side-scatter profiles were used to gate on the proper cell populations. Fluorescence intensity of single-cells was measured for each appropriate channel.

Mathematical models {#s4-18}
-------------------

### Note {#s4-18-1}

MATLAB Code for models has been deposited on GitHub (<https://github.com/nnandago/elife2018-cis_activation_modeling>; copy archived at <https://github.com/elifesciences-publications/elife2018-cis_activation_modeling>).

### Models {#s4-18-2}

The models analyzed here attempt to recapitulate the behavior of the system at steady state. Components of the system include free Notch receptor (N) and free Delta ligand (D) and, depending on the model, *cis*- and *trans*-complexes (C^+^/C^-^, and T, respectively) between ligands and receptors. In all models, N and D are produced at a rate of α~N~ and α~D~, and degraded at the rate of γ~N~ and γ~D~, respectively.

#### I) Model 0 {#s4-18-2-1}

This model assumes that N and D interact at a rate *k*^+^ to produce a single type of *cis*-complex, C^+^, which dissociates at a rate *k^-^*, and is degraded at a rate γ~C+~. That is,$$\begin{matrix}
{\frac{dN}{dt} = \alpha_{N} - \gamma_{N}N - k_{C +}^{+}ND + k_{C +}^{-}C^{+}} \\
 \\
{\frac{dD}{dt} = \alpha_{D} - \gamma_{D}D - k_{C +}^{+}ND + k_{C +}^{-}C^{+}} \\
 \\
{\frac{dC^{+}}{dt} = - \gamma_{C +}C^{+} + k_{C +}^{+}ND - k_{C +}^{-}C^{+}} \\
\end{matrix}$$

#### II) Model 1 {#s4-18-2-2}

This model assumes that N and D can interact to produce two distinct *cis*-complexes, active C^+^ and inactive C^-^. These complexes are formed through similar second-order interactions between N and D, occurring with different rate coefficients. They similarly dissociate and degrade at different rates, and cannot interconvert.$$\begin{matrix}
\frac{dN}{dt} & {= \alpha_{N} - \gamma_{N}N - k_{C +}^{+}ND + k_{C +}^{-}C^{+} - \ k_{C -}^{+}ND + k_{C -}^{-}C^{-}} \\
 & \\
\frac{dD}{dt} & {= \alpha_{D} - \gamma_{D}D - k_{C +}^{+}ND + k_{C +}^{-}C^{+} - \ k_{C -}^{+}ND + k_{C -}^{-}C^{-}} \\
 & \\
\frac{dC^{+}}{dt} & {= - \gamma_{C +}C^{+} + k_{C +}^{+}ND - k_{C +}^{-}C^{+}} \\
 & \\
\frac{dC^{-}}{dt} & {= - \gamma_{C -}C^{-} + k_{C -}^{+}ND - k_{C -}^{-}C^{-}} \\
\end{matrix}$$

#### III) Models 2a-d {#s4-18-2-3}

These models also assume that N and D can interact to produce two distinct *cis*-complexes, C^+^ and C^-^. However, in these models, C^-^ requires C^+^ for its formation (a-c) or the stoichiometry of inactive C^-^ formation is higher than that of C^+^ (d).$$\begin{matrix}
 & {{\mathbf{a})}\,\,\mathbf{N} + \mathbf{D}\ \leftrightarrow\mathbf{C}^{+},\ \mathbf{N} + \mathbf{D} + \mathbf{C}^{+}\ \leftrightarrow\mathbf{C}^{-}} \\
 & \\
\frac{dN}{dt} & {= \alpha_{N} - \gamma_{N}N - k_{C +}^{+}ND + k_{C +}^{-}C^{+} - \ k_{C -}^{+}NDC^{+} + k_{C -}^{-}C^{-}} \\
 & \\
\frac{dD}{dt} & {= \alpha_{D} - \gamma_{D}D - k_{C +}^{+}ND + k_{C +}^{-}C^{+} - \ k_{C -}^{+}NDC^{+} + k_{C -}^{-}C^{-}} \\
 & \\
\frac{dC^{+}}{dt} & {= - \gamma_{C +}C^{+} + k_{C +}^{+}ND - k_{C +}^{-}C^{+} - \ k_{C -}^{+}NDC^{+} + k_{C -}^{-}C^{-}} \\
 & \\
\frac{dC^{-}}{dt} & {= - \gamma_{C -}C^{-} + k_{C -}^{+}NDC^{+} - k_{C -}^{-}C^{-}} \\
\end{matrix}$$$$\begin{matrix}
 & {{\mathbf{b})}\,\,\mathbf{N} + \mathbf{D}\ \leftrightarrow\mathbf{C}^{+},\ \mathbf{C}^{+} + \mathbf{C}^{+}\ \leftrightarrow\mathbf{C}^{-}} \\
 & \\
\frac{dN}{dt} & {= \alpha_{N} - \gamma_{N}N - k_{C +}^{+}ND + k_{C +}^{-}C^{+}} \\
 & \\
\frac{dD}{dt} & {= \alpha_{D} - \gamma_{D}D - k_{C +}^{+}ND + k_{C +}^{-}C^{+}} \\
 & \\
\frac{dC^{+}}{dt} & {= - \gamma_{C +}C^{+} + k_{C +}^{+}ND - k_{C +}^{-}C^{+} - \ k_{C -}^{+}\left( C^{+} \right)^{2} + 2k_{C -}^{-}C^{-}} \\
 & \\
\frac{dC^{-}}{dt} & {= - \gamma_{C -}C^{-} + k_{C -}^{+}\left( C^{+} \right)^{2} - k_{C -}^{-}C^{-}} \\
\end{matrix}$$$$\begin{matrix}
 & {{\mathbf{c})}\,\,\mathbf{N} + \mathbf{D}\ \leftrightarrow\mathbf{C}^{+},\ \mathbf{D} + \mathbf{C}^{+}\ \leftrightarrow\mathbf{C}^{-}} \\
 & \\
\frac{dN}{dt} & {= \alpha_{N} - \gamma_{N}N - k_{C +}^{+}ND + k_{C +}^{-}C^{+}} \\
 & \\
\frac{dD}{dt} & {= \alpha_{D} - \gamma_{D}D - k_{C +}^{+}ND + k_{C +}^{-}C^{+} - \ k_{C -}^{+}DC^{+} + k_{C -}^{-}C^{-}} \\
 & \\
\frac{dC^{+}}{dt} & {= - \gamma_{C +}C^{+} + k_{C +}^{+}ND - k_{C +}^{-}C^{+} - \ k_{C -}^{+}DC^{+} + k_{C -}^{-}C^{-}} \\
 & \\
\frac{dC^{-}}{dt} & {= - \gamma_{C -}C^{-} + k_{C -}^{+}DC^{+} - k_{C -}^{-}C^{-}} \\
\end{matrix}$$$$\begin{matrix}
 & {{\mathbf{a})}\,\,\mathbf{N} + \mathbf{D}\ \leftrightarrow\mathbf{C}^{+},\ 2\mathbf{N} + 2\mathbf{D}\ \leftrightarrow\mathbf{C}^{-}} \\
 & \\
\frac{dN}{dt} & {= \alpha_{N} - \gamma_{N}N - k_{C +}^{+}ND + k_{C +}^{-}C^{+} - k_{C -}^{+}N^{2}D^{2} + 2k_{C -}^{-}C^{-}} \\
 & \\
\frac{dD}{dt} & {= \alpha_{D} - \gamma_{D}D - k_{C +}^{+}ND + k_{C +}^{-}C^{+} - k_{C -}^{+}N^{2}D^{2} + 2k_{C -}^{-}C^{-}} \\
 & \\
\frac{dC^{+}}{dt} & {= - \gamma_{C +}C^{+} + k_{C +}^{+}ND - k_{C +}^{-}C^{+}} \\
 & \\
\frac{dC^{-}}{dt} & {= - \gamma_{C -}C^{-} + k_{C -}^{+}N^{2}D^{2} - k_{C -}^{-}C^{-}} \\
\end{matrix}$$

#### IV) Model 2c + trans-interactions {#s4-18-2-4}

To model the effect of trans-interactions in the context of model 2c, it was assumed that the *trans-*complex T is formed through interactions between N and *trans* Delta (D*~trans~*, assumed to be constant). The rate coefficients of its formation, dissociation, and degradation are assumed to be the same as that of C^+^.$$\begin{matrix}
 & {\mathbf{N} + \mathbf{D}_{\mathbf{c}\mathbf{i}\mathbf{s}}\ \leftrightarrow\mathbf{C}^{+},\ \mathbf{D}_{\mathbf{c}\mathbf{i}\mathbf{s}} + \mathbf{C}^{+}\ \leftrightarrow\mathbf{C}^{-},\ \mathbf{N} + \mathbf{D}_{\mathbf{t}\mathbf{r}\mathbf{a}\mathbf{n}\mathbf{s}}\ \leftrightarrow\mathbf{T}} \\
 & \\
\frac{dN}{dt} & {= \alpha_{N} - \gamma_{N}N - k_{C +}^{+}ND_{cis} + k_{C +}^{-}C^{+} - k_{C +}^{+}ND_{trans} + k_{C +}^{-}T} \\
 & \\
\frac{dD_{cis}}{dt} & {= \alpha_{D} - \gamma_{D}D_{cis} - k_{C +}^{+}ND_{cis} + k_{C +}^{-}C^{+} - \ k_{C -}^{+}D_{cis}C^{+} + k_{C—}^{-}C^{-}} \\
 & \\
\frac{dC^{+}}{dt} & {= - \gamma_{C +}C^{+} + k_{C +}^{+}ND_{cis} - k_{C +}^{-}C^{+} - \ k_{C -}^{+}D_{cis}C^{+} + k_{C—}^{-}C^{-}} \\
 & \\
\frac{dT}{dt} & {= - \gamma_{C +}T + k_{C +}^{+}ND_{trans} - k_{C +}^{-}T} \\
\end{matrix}$$

### Parameter scan, numerical simulations, and analyses {#s4-18-3}

Model 0 contains 6 parameters ($\left. \alpha_{N},\gamma_{N},\gamma_{D},\gamma_{C +},k_{C +}^{+},k_{C +}^{-} \right)$, while Models 1 and 2 contain 3 additional parameters ($\gamma_{C -},k_{C -}^{+},k_{C -}^{-}$). Using the built-in *lhsdesign* function in MATLAB (2015a, Mathworks), the Latin Hypercube Sampling algorithm was applied to pick 10,000 parameters, each in the range 10^−2^ to 10^2^. For each parameter set, the model was simulated for each of 10 values of $\alpha_{D}$, logarithmically spanning a 100-fold range around the sampled value of $\alpha_{N}$. The *fsolve* function, with initial conditions \[$\frac{\alpha_{N}}{\gamma_{N}},\frac{\alpha_{D}}{\gamma_{D}},1,1$\] for N, D, C^+^, C^-^, respectively, was used to numerically approximate the steady state solution for each parameter set.

For each solution, the following features of the $\alpha_{D}$ vs. C^+^ profile were calculated: the relative value of $\alpha_{D}$ at which C^+^ was maximum ('C-max'), and the fractional increases in C-max relative to its value at the lowest and highest values of$\alpha_{D}$. Parameters that produced C^+^ profiles that peaked between the 1^st^ and 8^th^ value of $\alpha_{D}$ were deemed to be non-monotonic.

For the *trans-*interaction model, first the values of D*~cis~* obtained at D*~trans~* = 0 were calculated for each parameter set. For subsequent simulations, the values of D*~trans~* were chosen to be the same as that of these D*~cis~* values, that is D*~cis~* produced in the absence of *trans-*ligand.

Statistics {#s4-19}
----------

No statistical method was used to determine sample sizes. The sample sizes used were based on general standards accepted by the field. The number of replicates used for each experimental analysis is listed in the figure legends. All replicates are biological replicates, corresponding to measurements performed on distinct biological samples, as opposed to performing the same tests multiple times on a single sample (technical replicates). *P-*values for [Figures 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"} were calculated using the two-sided KS-test. All pairwise comparisons between samples fulfilled the criterion n1\*n2/(n1 + n2)≥4, where n1 and n2 represent the number of data points in two samples. Under this condition, the KS-statistic is greater than twice the inverse of the Kolmogorov statistic, and the calculated *P-*value is accurate. The non-parametric nature of the KS-test obviates the need to make assumptions regarding the shape of the distributions being compared. *P-*values for Caco-2 cell measurements ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}) and CHO cell surface binding assay measurements ([Figure 4](#fig4){ref-type="fig"}) were calculated using the one-sided Student T-test, which assumes that random error in the measurement follows a normal (Gaussian) distribution.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"*Cis*-activation in the Notch signaling pathway\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Naama Barkai as the Senior and Reviewing Editor. The following individual involved in review of your submission has agreed to reveal his identity: Andre Levchenko (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The authors present evidence for a new mechanism of Notch receptor activation by which cis-ligands can activate Notch receptors on the same cell. They find that cis-activation is governed by ligand concentration, cis-inhibition, and Fringe glycosylation, and extends to Dll1/Dll4 and Notch1/2 receptor pairs. Notch ligands and receptors co-expressed in the same cell have been known to mutually inhibit one another, suppressing productive intercellular signaling the fact that cis-ligands can also activate Notch receptors is surprising and potentially highly significant. The authors further simulate scenarios to best describe the complexes and kinetics that can contribute to the co-existence of both cis- and trans-activation, and postulate on how this new mechanism may expand the capabilities of Notch signaling. This finding adds another level of complexity to the Notch signaling pathway that might have important consequences in other biological contexts.

Although many aspects of the underlying mechanisms remain puzzling, this manuscript presents a body of very well done work, including data not only characterizing the phenomenon, but also suggesting its functional significance (e.g., enhancing survival of neural stem cells). I do have several comments, focusing on points requiring further analysis and clarification:

The major limitation of this work is that the majority of observations were derived from synthetic Notch receptors in CHO cells. It is therefore of critical importance that the authors rigorously demonstrate that such a mechanism is utilized naturally. Specifically, please address the following essential comments:

1\) In Figure 1---figure supplement 3, CRISPR deletion of *Notch2* and Jagged1 are performed in murine NMuMG cells, but the relevant manipulations are made using synthetic Dll1 and Notch1 constructs. The reasoning for this is unclear. Western blot profiling of NMuMG lysates showing expressed Notch receptors and ligands at the protein level, along with successful CRISPR depletion is needed. Genetic depletion followed by expression of the corresponding wild type receptor and inducible wild type ligand should be performed. Does eventual cis-inhibition occur (Figure 1---figure supplement 3F)? And if so, at what expression level in comparison to endogenously expressed ligand?

2\) The NSC experiments in Figure 3 rely entirely on the γ-secretase inhibitor DAPT. Γ-secretase has numerous substrates outside of the Notch receptors and their ligands that can contribute to decreased proliferation and differentiation, and does not directly link this effect to Notch cis-activation.

3\) Figure 1---figure supplement 4, the Caco-2 experiments rely on DAPT (100 uM!). Again, this indirect inhibitor does not directly implicate Notch activation. Genetic depletion followed by expression of wild type receptor and inducible wild type ligand would be ideal (as in Figure 1---figure supplement 3A).

In addition, please consider the following suggestions:

1\) It is interesting that all cis-activation assays were completed in monolayer cultures using a small percentage of expressing cells. It would seem that manipulating ligand expression in single, isolated cells would most rigorously demonstrate this mechanism, albeit at lower throughput. Is there some element of cell-cell contact that is required? It is a bit concerning that the synthetic Notch receptors show both impaired and cell-contact dependence in their localization (Figure 1figure supplement 3D) compared to a more complete wild type Notch receptor, particularly as the authors describe that cis-activation occurs on the cell membrane and not in endosomal compartments (Figure 4). This further illustrates the need to clearly demonstrate this mechanism with wild type receptors, ligands, and in human cells.

2\) Subsection "*Notch2* shows stronger cis-activation but decreased cis-inhibition compared to Notch1": In Figure2D, the profile of activation was monotonic, and it was stated that Notch 2 is not cis-inhibited as strongly as Notch 1. If the cis-inhibition needs the formation of larger ligand-receptor cluster as mentioned in Discussion, does it imply Notch 2 his less/more effective as a molecule nucleating such clusters?

3\) Discussion, fourth paragraph: It is mentioned that autocrine and juxtacrine signaling modes lead to different biological outcomes. It would be great if authors briefly summarize what the outcomes are.

4\) Subsection "Cis-activation regulates neural stem cell maintenance and differentiation", last paragraph: It is claimed that DAPT treatment altered expression patterns of markers in Figure 3---figure supplement 2B. However, the patterns of untreated and DAPT look overlapping in the figure. Please specify the degree of the presumed alteration, and how one can decipher it.

5\) Figure 1---figure supplement 2B: As the percentage of engineered cells in wild type cell population is critical in this study, it will be more intuitive to represent the cell number of Y-axis in the form percentage or ratio.

6\) Subsection "Notch1-Dll1 cells show ligand-dependent cis-activation", sixth paragraph: The way authors interpret Figure 1---figure supplement 4, it would appear that cis-activation in sparsely plated CaCo-2 is similar to cis +trans activation in densely plated CaCo-2. First, it is not obvious because Figure1---figure supplement 4A and B are represented as the fold change relative to DAPT control in each condition. Please represent the values normalized to the same control. Also, please mention it in the figure caption. Second, this result is different from the previous results in Figure1---figure supplement 2C which showed that cis-trans activation is much higher than cis activation. This needs further analysis/explanation.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Cis-activation in the Notch signaling pathway\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Naama Barkai (Senior Editor) and two reviewers.

The reviewers would like to see your paper published in *eLife*, conditioned that you add a western blot that shows the extent of Dll1 depletion in Figure 3 and supports the claim that \"Dll1 siRNA treatment also decreased survival, albeit more weakly, likely due to the incomplete knockdown (Figure 3C, right panel)\".

*Reviewer \#1:*

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below.

Major concerns regarding the use of synthetic receptors and ectopic ligands and their proper localization are adequately addressed within the new manuscript. The authors have expanded their original document to include Notch activation in sparse cells with endogenous receptors and ligands as well as ectopic ligands, as in Figure 1---figure supplement 4. Importantly, the authors also provide insight into what expression levels relative to endogenous Dll1 contribute to cis-activation and -inhibition, respectively.

The concerns regarding the use of DAPT as the sole method to explore the effect of Notch cis-activation on proliferation has been satisfactorily addressed in the document with experiments using silencing RNA to Dll1, Dll1 surface plating, and lower concentrations of DAPT (10uM, Figure 1---figure supplement 4). While, we find this approach satisfactory, a Western blot is necessary to show extent of Dll1 depletion in Figure 3 and to support the following claim \"Dll1 siRNA treatment also decreased survival, albeit more weakly, likely due to the incomplete knockdown (Figure 3C, right panel)\".

*Reviewer \#2:*

I reviewed the manuscript and the answers. Basically, the authors revised the manuscript according to only two of my initial comments. I think those parts were revised properly. But, for the other three comments, they just retracted their claims, removed the figures, or stated that \"they would like to follow up on it in the future\". Although it might not be the best way to handle the criticisms, I am okay with these changes, considering that they do not undermine their major claims or change the overall message. Overall, it is a well thought-through story and the edits tightened it up and focused on the main claims, which are well supported. I am ok with giving the manuscript the green light for acceptance.
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Author response

> \[...\] Although many aspects of the underlying mechanisms remain puzzling, this manuscript presents a body of very well done work, including data not only characterizing the phenomenon, but also suggesting its functional significance (e.g., enhancing survival of neural stem cells). I do have several comments, focusing on points requiring further analysis and clarification:
>
> The major limitation of this work is that the majority of observations were derived from synthetic Notch receptors in CHO cells. It is therefore of critical importance that the authors rigorously demonstrate that such a mechanism is utilized naturally. Specifically, please address the following essential comments:
>
> 1\) In Figure 1---figure supplement 3, CRISPR deletion of Notch2 and Jagged1 are performed in murine NMuMG cells, but the relevant manipulations are made using synthetic Dll1 and Notch1 constructs. The reasoning for this is unclear.

We agree this was unclear as originally presented. The goal of the experiment was to determine whether engineered Notch1 and Dll1 constructs, which were shown to cis-activate in CHO-K1 could also cis-activate in a different cell type (NMuMG cells). Deletion of *Notch2* and Jagged1 was done to eliminate the potential for competition between the ectopic components (Dll1, Notch1) and the endogenous components (principally Jag1, *Notch2*). We now show (Figure 1---figure supplement 3B, right panel) that deletion of these components is required to observe signaling between the ectopic Dll1 and Notch1. To address this issue, we clarified the reasoning behind these experiments in the text. Furthermore, we also show that endogenous *Notch2* and Jag1 can cis-activate (see below).

> Western blot profiling of NMuMG lysates showing expressed Notch receptors and ligands at the protein level, along with successful CRISPR depletion is needed.

We now show, through Western Blot analysis, the successful CRISPR deletion of *Notch2* and Jagged1 protein in our NMuMG cells (Figure 1---figure supplement 3B, middle).

> Genetic depletion followed by expression of the corresponding wild type receptor and inducible wild type ligand should be performed.

We make three points in the NMuMG context:

1\) Cis-activation between ectopic ligand and receptor.By deleting endogenous Jag1 and *Notch2*, and ectopically expressing Dll1 and Notch1, we show that cis-activation can occur between the ectopic ligand and receptor in a cell type distinct from CHO-K1 (Figure 1---figure supplement 3F, G). This result was included in the original version.

2\) Cis-activation between endogenous receptor and ectopic ligand. Endogenous *Notch2* can be *cis-*activated by ectopic expression of Dll1, as shown using RT-qPCR and single-cell HCR-FISH measurements of Hes1 with or without DAPT treatment (Figure 1---figure supplement 4B-D). This result is new to this version.

*3)* Cis-activation between endogenous receptor and endogenous ligand. Consistent with *cis-*activation between endogenous Jag1 and *Notch2*, Hes1 expression also exhibits a modest reduction in response to DAPT addition in the absence of any ectopic components (Figure 1---figure supplement 4B-D). This result is new to this version.

The above mentioned results, as explained in the manuscript, support the claim that *cis*-activation occurs endogenously as well as with ectopic components in isolated NMuMG cells.

> Does eventual cis-inhibition occur (Figure 1---figure supplement 3F)? And if so, at what expression level in comparison to endogenously expressed ligand?

We addressed this question with two new experiments:

First, to address this question, we extended the range of Dll1 expression levels by transiently transfecting a Dll1-mCherry construct and gating the flow cytometry data on different mCherry windows. These experiments revealed a non-monotonic dependence on Dll1 expression (Figure 1---figure supplement 3G), similar to that observed in CHO-K1 cells.

Second, using RNAseq, we compared the expression level of ectopic Dll1 in NMuMG N1D1+Rfng cells to endogenous Jag1 expression in wild-type NMuMG cells. As shown in Figure 1---figure supplement 3G (black bars on right), the levels of ectopic Dll1 expression that show peak cis-activation responses are similar to the expression levels of endogenous Jag1. Above this level, one starts to observe cis-inhibition (decreasing green bars). These results suggest that the levels of Dll1 required for cis-activation are comparable to endogenous ligand levels, and also support cis-inhibition dominating at higher ligand expression levels.

> 2\) The NSC experiments in Figure 3 rely entirely on the γ-secretase inhibitor DAPT. Γ-secretase has numerous substrates outside of the Notch receptors and their ligands that can contribute to decreased proliferation and differentiation, and does not directly link this effect to Notch cis-activation.

In NSCs, we sought to test whether increasing or decreasing Notch signaling could lead to increased or decreased proliferation, respectively. Previously, we used DAPT to decrease signaling and observed a corresponding decrease in cell proliferation. We also demonstrated that NSCs plated on recombinant Dll1ext-IgG leads to a striking increase in cell numbers. Thus modulation of Notch signaling in either direction produced a corresponding effect on proliferation.

To address the reviewer\'s concern about potential off target effects of DAPT, we added new experiments using siRNA to knock down Dll1 expression. Dll1 knockdown decreased survival of isolated NSCs in low growth factor conditions, consistent with expectations from the DAPT results (Figure 3C). The magnitude of this effect is weaker than obtained with DAPT, likely because of incomplete knockdown. Nevertheless, together with the previous results, these findings are consistent with Notch signaling in isolated cells (cis-activation) impacting proliferation (Figure 3C and D). They are also consistent with previous work showing a positive effect of Notch signaling on proliferation in NSCs, particularly in the absence of growth factors (Nagao et al., 2007). In addition to including the new results in the manuscript, we also now explicitly emphasize that while we cannot rule out a non-specific effect of DAPT, our results are consistent with an effect of Notch on proliferation.

> 3\) Figure 1---figure supplement 4, the Caco-2 experiments rely on DAPT (100 uM!). Again, this indirect inhibitor does not directly implicate Notch activation. Genetic depletion followed by expression of wild type receptor and inducible wild type ligand would be ideal (as in Figure 1---figure supplement 3A).

We originally chose to use a DAPT concentration of 100 µM based on previous work analyzing Notch signaling in Caco-2 cells (Hsieh, En Hui and Lo, 2012). However, we have re-performed the Caco-2 experiments using 10µM DAPT (similar DAPT levels were used for the NMuMG and NSC experiments) and observed similar results. The corresponding figure has now been updated to reflect the new data (Figure 1---figure supplement 4A). We agree that the ideal experiment would be done with specific genetic manipulations. However, Caco-2 cells are very slow growing (doubling time is 3-4 days), and therefore genetic manipulation would require extended timescales before resubmission.

> In addition, please consider the following suggestions:
>
> 1\) It is interesting that all cis-activation assays were completed in monolayer cultures using a small percentage of expressing cells. It would seem that manipulating ligand expression in single, isolated cells would most rigorously demonstrate this mechanism, albeit at lower throughput. Is there some element of cell-cell contact that is required?

We agree that analysis of isolated cells is most compelling. Originally, the surrounding CHO-K1 cells were used to reduce cell movement. To confirm that these cells are not necessary, we now show that the same *cis*-activation behavior occurs in N1D1+Rfng cells plated sparsely, without surrounding wild-type CHO-K1 cells. These results indicate that the phenomenon does not depend on the overall cell density (Figure 1---figure supplement 2B).

Further, the two results together strengthen the conclusions of the paper: Mammalian cells are rarely in isolation in natural contexts. The appearance of cis-activation in densely cultured cells shows that it is not an artifact of isolation.

> It is a bit concerning that the synthetic Notch receptors show both impaired and cell-contact dependence in their localization (Figure 1figure supplement 3D) compared to a more complete wild type Notch receptor, particularly as the authors describe that cis-activation occurs on the cell membrane and not in endosomal compartments (Figure 4). This further illustrates the need to clearly demonstrate this mechanism with wild type receptors, ligands, and in human cells.

The points about subcellular localization were confusing as originally presented, and we have now clarified these points in the text. Briefly:

\- In CHO-K1 cells, we observed no discernable difference in localization between wild-type and Notch1ECD-Gal4 receptors (Figure 1---figure supplement 3E), consistent with the non-polarized nature of CHO-K1 cells.

\- However, in NMuMG cells, which do polarize, we found that the ankyrin domain present in the wild-type Notch ICD was necessary for proper localization, as expected based on previous work (Sasaki et al., 2007; Benhra et al., 2010 and 2011). Including this in the Gal4 receptor restored localization and function.

Thus, the localization issue with the synthetic NotchGal4 system was specific to NMuMG and could be circumvented by including more of the WT receptor intracellular domain. We now clarify this point in the text (subsection "Notch1-Dll1 cells show ligand-dependent cis-activation", fifth paragraph).

> 2\) Subsection "Notch2 shows stronger cis-activation but decreased cis-inhibition compared to Notch1": In Figure2D, the profile of activation was monotonic, and it was stated that Notch 2 is not cis-inhibited as strongly as Notch 1. If the cis-inhibition needs the formation of larger ligand-receptor cluster as mentioned in Discussion, does it imply Notch 2 his less/more effective as a molecule nucleating such clusters?

This suggestion that the difference in signaling may reflect differences in cluster nucleation is very interesting. While we were not able to address it here, we would like to follow up on it in the future with better assays for cluster formation.

> 3\) Discussion, fourth paragraph: It is mentioned that autocrine and juxtacrine signaling modes lead to different biological outcomes. It would be great if authors briefly summarize what the outcomes are.

We have added a brief summary of the differing biological outcomes that autocrine and juxtacrine signaling modes can lead to. Briefly, HB-EGF can occur as two isoforms: a membrane-anchored precursor that is involved in juxtacrine signaling or a cleaved soluble form that is involved in autocrine signaling. In MDCK cells, distinct cell phenotypes were found to occur depending upon which HB-EGF isoform was expressed, and cell survival and proliferation appeared to increase with the presence of the membrane-anchored isoform (Raab and Klagsbrun 1997; Singh, Sugimoto, and Harris 2007). Similarly, in yeast, rewiring of the mating pathway to create an autocrine signaling system revealed that qualitatively different behaviors ranging from quorum sensing to bimodality could be generated by tuning the relative strengths of *cis* and *trans* signaling (Youk and Lim 2014). These points are now included in the text.

> 4\) Subsection "Cis-activation regulates neural stem cell maintenance and differentiation", last paragraph: It is claimed that DAPT treatment altered expression patterns of markers in Figure 3---figure supplement 2B. However, the patterns of untreated and DAPT look overlapping in the figure. Please specify the degree of the presumed alteration, and how one can decipher it.

The effects on marker expression are modest at this time-point. The difficulty here is that larger effects on differentiation require longer durations, by which point cell divisions occur and we can no longer eliminate possible intercellular signaling. Based on these considerations, we removed this figure and the corresponding claims about differentiation.

> 5\) Figure 1---figure supplement 2B: As the percentage of engineered cells in wild type cell population is critical in this study, it will be more intuitive to represent the cell number of Y-axis in the form percentage or ratio.

We agree and appreciate the suggestion. The changes are incorporated in the figures.

> 6\) Subsection "Notch1-Dll1 cells show ligand-dependent cis-activation", sixth paragraph: The way authors interpret Figure 1---figure supplement 4, it would appear that cis-activation in sparsely plated CaCo-2 is similar to cis +trans activation in densely plated CaCo-2. First, it is not obvious because Figure1---figure supplement 4A and B are represented as the fold change relative to DAPT control in each condition. Please represent the values normalized to the same control. Also, please mention it in the figure caption. Second, this result is different from the previous results in Figure1---figure supplement 2C which showed that cis-trans activation is much higher than cis activation. This needs further analysis/explanation.

Because Caco-2 cells grow slowly (as mentioned above), both low and high density conditions were in fact much lower than corresponding densities in the CHO-K1 experiments. In fact, the higher density condition in the Caco-2 experiments is still quite sparse and therefore behaves similarly to the lower density condition. For this reason, and because the density dependence in Caco-2 was not essential for main claims, we removed it in the revised version.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The reviewers would like to see your paper published in eLife, conditioned that you add a western blot that shows the extent of Dll1 depletion in Figure 3 and supports the claim that \"Dll1 siRNA treatment also decreased survival, albeit more weakly, likely due to the incomplete knockdown (Figure 3C, right panel)\".

Reviewer \#1:

> The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below.
>
> Major concerns regarding the use of synthetic receptors and ectopic ligands and their proper localization are adequately addressed within the new manuscript. The authors have expanded their original document to include Notch activation in sparse cells with endogenous receptors and ligands as well as ectopic ligands, as in Figure 1---figure supplement 4. Importantly, the authors also provide insight into what expression levels relative to endogenous Dll1 contribute to cis-activation and -inhibition, respectively.
>
> The concerns regarding the use of DAPT as the sole method to explore the effect of Notch cis-activation on proliferation has been satisfactorily addressed in the document with experiments using silencing RNA to Dll1, Dll1 surface plating, and lower concentrations of DAPT (10uM, Figure 1---figure supplement 4). While, we find this approach satisfactory, a Western blot is necessary to show extent of Dll1 depletion in Figure 3 and to support the following claim \"Dll1 siRNA treatment also decreased survival, albeit more weakly, likely due to the incomplete knockdown (Figure 3C, right panel)\".

We thank you and the reviewers for the favorable review of the manuscript. As requested by reviewer 1, we have now updated Figure 3 to include a western blot that shows the level of Dll1 after siRNA treatment in neural stem cells. Specifically, this data shows that Dll1 protein is reduced after siRNA treatment, but not completely eliminated, supporting the claim \"Dll1 siRNA treatment also decreased survival, albeit more weakly, likely due to the incomplete knockdown of Dll1 protein levels\". We have now updated the relevant text to include a citation to the new data, and updated the corresponding figure legend and Materials and methods section to reflect the addition.

[^1]: These authors contributed equally to this work.
